~ Power House ~

[ProfitScout]

$NRXP News: NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com

"How NRx Could Upend the Fight Against Depression and Suicide"

RADNOR, Pa., Sept. 11, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, ("NRx," the "Company"), today highlighted that the Company's pipeline products NRX-100 and NRX-101 were featured in an article published on Psychiatrist.com. This prominent outlet is the home of the Journal of Clinical Psychiatry, the official journal of the American Society of Clinical Psychopharmacology.

The article, entitled "How NRx Could Upend the Fight Against Depression and Suicide," can be found here. The author notes:

"Clinical relevance: NRX Pharmaceuticals is developing a pair of promising new treatments for bipolar depression and suicidal ideation."
"NRX-101 is a twice-daily fixed-dose oral combination of D-cycloserine and lurasidone the company developed to treat suicidal treatment-resistant bipolar depression. Researchers found this combination showed a higher efficacy than lurasidone alone for reducing akathisia and suicidality."
"NRX-100 is a proprietary preservative-free formulation of IV ketamine. Researchers have studied it as a treatment for acute suicidal crises in depression."
For more information, please visit http://www.nrxpharma.com.

About NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.

NRx has recently announced plans to submit a New Drug Application for NRX-100 (IV ketamine) for the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.

Notice Regarding Forward-Looking Statements

The information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These statements include, among others, statements regarding the proposed public offering and the timing and the use of the proceeds from the offering. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. Except as may be required by applicable law, The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise.

For further information:

CORPORATE CONTACTS:
Jeremy Feffer, LifeSci Advisors, Inc.
[e-mail]

Matthew Duffy
Chief Business Officer, NRx Pharmaceuticals
Co-CEO, HOPE Therapeutics, Inc.
[e-mail]

https://c212.net/c/img/favicon.png?sn=CL03022&sd=2024-09-11 View original content to download multimedia:https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaqnrxp-featured-on-psychiatristcom-302244304.html

SOURCE NRx Pharmaceuticals, Inc.

[ProfitScout]

$IDVV News: IEC Announces Update on Winners Waygers AI Powered Sports Handicapping Assistant

Las Vegas, Nevada--(Newsfile Corp. - September 10, 2024) - International Endeavors Corp. (OTC PINK: IDVV) ("IEC"), a technology holdings company announced that its artificial intelligence (AI) powered sports handicapping assistant has received additional pro subscribers, and its free beta version has topped 4000 subscribers.

Previously the company announced the launch of http://winnersaygers.com, a one of a kind artificial intelligence (AI) powered sports handicapping program in beta mode. Today we are pleased to announce that the free beta service has already received 4000 subscribers.

Current subscribers are being given picks that the AI is generating for the current NFL season, and plans are to convert subscribers to several paid options towards the end of October as the AI learns more data during the current season and becomes more efficient in its strategy. Last season the AI had over a 60% win rate, with an increasingly better win rate as the season progresses and the AI is able to use more up to date information. The current focus is building subscribers while perfecting the AI's thought process.

We have received additional subscribers for the professional AI handicapping version. Used by professional handicappers that helped to develop the tools and datasets for the AI. The pro tools do not make picks for professionals, but instead help them to acquire data at a much faster pace and allow them to increase their action. We anticipate reaching up to 100 subscribers by year end. Due to that nature of the handicapping community, Pro subscribers are acquired by referrals. Each paying a negotiable signup fee of up to $10,000 per license along with a monthly subscription of $1000 to $2000.

Winners Waygers spokesperson Marrion Lewis stated "We are on track with offering the service to the mainstream. Converting the pro version to a more user friendly mainstream style has been an undertaking, but one that our team is doing well. We're confident that a product will be there that can revolutionize the industry."

Winners Waygers Video
https://vimeo.com/999064151?share=copy

Relevant Links
https://www.americangaming.org/resources/economic-impact-of-legalized-sports-betting/
https://www.statista.com/topics/10895/fantasy-sports-in-the-us/#topicOverview
https://www.espn.com/nfl/story/_/id/39469575/americans-expected-bet-231b-super-bowl-lviii

We encourage everyone to follow us.

Twitter
https://twitter.com/IDVVcorp

Website(s)
https://witech.ai
https://IDVVCORP.COM
https://winnerswaygers.com

About Us

International Endeavors Corporation ("IEC") is a technology holdings company.
The Company currently is reporting its financial information on OTCMarkets.
Our filings can be seen at https://www.otcmarkets.com

Disclaimer

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. International Endeavors Corporation (IDVV) is under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact:

International Endeavors Corporation
Phone: [phone]
Email: [e-mail]

SOURCE: International Endeavors Corporation, Inc.

https://images.newsfilecorp.com/files/10187/222813_21b8d136c42aeaa5_logo.jpg

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/222813

SOURCE International Endeavors Corporation

https://api.newsfilecorp.com/newsinfo/222813/130

[ProfitScout]

$NRXP News: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Alignment with FDA on Pediatric Study Plan for NRX-100 (ketamine)

FDA response highlights the importance of addressing suicidal depression in adolescents age 9-17

Alignment on initial Pediatric Study Plan (iPSP) is a gating requirement for the upcoming filing of an NRX-100 New Drug Application (NDA) for suicidal depression

NRx remains on track to file the NDA for NRX-100 in Q4 2024 with anticipated PDUFA date in Q2 2025

RADNOR, Pa., July 29, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical stage pharmaceutical company, today announced a communication from the US Food and Drug Administration (FDA) providing feedback and alignment on NRx's proposed initial Pediatric Study Plan (iPSP) for NRX-100 (ketamine) in the treatment of suicidal depression. Congress required the submission of an iPSP as a precondition to filing a New Drug Application in the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).[1]

Suicide is a growing crisis among adolescents in the United States. According to the US Centers for Disease Control, 10% of high school students attempted suicide in the past year and 22% of high school students reported having seriously considered suicide. This percentage is highest among females (30%), American Indians/Alaska Natives (27%), and lesbian, gay, or bisexual teens (45%) (CDC, 2023). [2]

In support of its upcoming NDA filing, NRx will be submitting existing data supporting the safety and efficacy of ketamine to treat suicidal depression in adults. FDA has now documented its recognition that suicide is a serious and growing public health concern in adolescents as well. Based on the guidance received, NRx and HOPE Therapeutics will commit to conducting a clinical trial of NRX-100 in adolescents aged 9-17 with suicidal depression, but will not be required to study the effects of NRX-100 in younger age groups, following initial approval of NRX-100 in adults. Additional neurotoxicity studies will be conducted in juvenile animal subjects to support the safety of intravenous ketamine in this younger population.

"Youth suicide has reached crisis proportions in the United States with a 62% increase over the past two decades, disproportionately affecting minorities.[3] We appreciate FDA's recognition of the urgent unmet medical need related to suicidal depression in adolescents and look forward to expanding the mission of NRx and HOPE Therapeutics to serve America's youth in preventing needless deaths from suicidal depression, said Prof. Jonathan Javitt, Chairman of NRx Pharmaceuticals and Co-CEO of HOPE Therapeutics."

About NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.

NRx has recently announced plans to submit a New Drug Application for NRX-100 (IV ketamine) for the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.

About HOPE Therapeutics, Inc.

HOPE Therapeutics, Inc. (www.hopetherapeutics.com) is a care delivery company developing a best-in-class network of clinics that currently offer ketamine and other lifesaving therapies to patients with suicidal depression and related disorders, together with a digital therapeutic-enabled platform designed to augment and preserve the clinical benefit of NMDA-targeted drug therapy.

Notice Regarding Forward-Looking Statements

The information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These statements include, among others, statements regarding the proposed public offering and the timing and the use of the proceeds from the offering. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. Except as may be required by applicable law, The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise.

1 https://www.hhs.gov/guidance/sites/default/files/hhs-guidance-documents/Pediatric-Study-Plans--Content-of-and-Process-for-Submitting-Initial-Pediatric-Study-Plans-and-Amended-Pediatric-Study-Plans.pdf
2 https://www.cdc.gov/healthyyouth/data/yrbs/pdf/YRBS_Data-Summary-Trends_Report2023_508.pdf
3 https://www.apa.org/monitor/2023/07/psychologists-preventing-teen-suicide


https://c212.net/c/img/favicon.png?sn=CL71115&sd=2024-07-29 View original content to download multimedia:https://www.prnewswire.com/news-releases/hope-therapeutics-inc-and-nrx-pharmaceuticals-inc-nasdaqnrxp-announce-alignment-with-fda-on-pediatric-study-plan-for-nrx-100-ketamine-302208338.html

SOURCE NRx Pharmaceuticals, Inc.

[ProfitScout]

$IVDN (16 million float) is about to file a banner quarterly report for its fiscal Q2 which will show that sales of its superior Insultex House Wrap product have already exceeded all of the company's results for the full 2023 fiscal year.

This has been pre-announced in the last two IVDN news releases:

Innovative Designs Sales Update
May 30, 2024
https://finance.yahoo.com/news/innovative-designs-sales-110000236.html

Innovative Designs Vendor Growth
April 10, 2024
https://finance.yahoo.com/news/innovative-designs-vendor-growth-174255528.html

[ProfitScout]

$CYCA News: CyttaAIR Partners with FIZUAS to Dominate the American Drone Reseller and Advanced Streaming Technology Market

Massive Florida Demand for CyttaCOMMS and Drones Drives Partnership

LAS VEGAS, NV / ACCESSWIRE / June 13, 2024 / Cytta Corp (OTCQB:CYCA), a leading provider of innovative technology solutions for public safety and cybersecurity industries, is excited to announce that CyttaAIR, in an expansion of its longstanding reseller partnership with FIZUAS Unmanned Aircraft Systems, a premier national drone reseller, is now entering the drone reseller market. This strategic joint venture aims to meet the growing demand for American-made drones, particularly from law enforcement agencies transitioning away from foreign drones.

A Strategic Move in Response to Growing Demand

This expanded partnership with FIZUAS comes at a critical time when numerous law enforcement agencies in Florida are seeking guidance on which drone brands and models to purchase. This transition to American-made drones is driven by legislative changes and a heightened focus on data security. Through this joint venture, CyttaAIR will provide these agencies with top-tier, compliant drone options, enhancing their operational capabilities and ensuring adherence to new regulations.

Quote from Mike Elliott, VP of Business Development

"We are thrilled to be partnering with a premiere national drone reseller like FIZUAS," said Mike Elliott, VP of Business Development at Cytta Corp. "The number of law enforcement agencies in Florida asking about which drone brands and models to purchase has skyrocketed. This joint venture allows CyttaAIR to expand into this rapidly growing market, providing our clients with the best in American-made drone technology and our leading CyttaCOMMS secure video streaming solution."

Expanding CyttaAIR's Reach

This collaboration is poised to position CyttaAIR as a dominant player in the drone reseller market. By leveraging FIZUAS's extensive reseller network and expertise, CyttaAIR/FIZUAS will jointly offer a comprehensive range of drones equipped with the secure and collaborative capabilities of CyttaCOMMS. This move underscores Cytta Corp.'s commitment to providing cutting-edge technology solutions that meet the evolving needs of law enforcement and other critical sectors.

About Cytta Corp:

Cytta Corp. is a leading technology solutions provider dedicated to delivering innovative products and services across various industries and revolutionizes the integration, streaming, transfer, and storage of video and audio data. With a focus on safety, security, and efficiency, Cytta Corp strives to develop cutting-edge solutions that address real-world challenges in large markets.

The Company's proprietary CyttaCOMMS incident management system offers real-time integration of video and audio streams, enabling improved collaboration and providing ongoing, relevant, actionable intelligence. Their innovative new product, CyttaCARES , is a game-changer in ensuring the safety and well-being of children in educational institutions and beyond. CyttaAIR, a groundbreaking platform designed to innovate and consolidate the best of drone hardware, software, and resources for Federal and State Law Enforcement Agencies. Cytta's CyttaCOMP ISTAR (Intelligence, Surveillance, Target Acquisition and Reconnaissance) technology delivers real-time compression of video streams with ultra-low latency.

About FIZUAS Unmanned Aircraft Systems

FIZUAS is a leading national drone reseller known for providing high-quality, reliable drone solutions to various industries. Their extensive network and extensive first responder and industry expertise make them a trusted partner for organizations looking to integrate drone technology into their operations.

Contact Information
Investor/Shareholder Contact:
Gary Zwetchkenbaum
PlumTree Consulting, LLC.
[e-mail]
Direct: (516)-455-7662

Cytta Corp.
Toll free #: 1 877 CYTTAUS (298 8287)
Call Local: 1 740 CYTTAUS (298 8287)
http://www.cytta.com
[e-mail]

Gary Campbell, CEO
Direct [phone] (or message)
[e-mail]

Mike Elliott, VP of Business Development
[e-mail]
[phone]

SOURCE: Cytta Corp.
https://finance.yahoo.com/news/cyttaair-partners-fizuas-dominate-american-120000070.html

[ProfitScout]

$AVRW News: Avenir Wellness Solutions Reports Fourth Quarter 2023 Results

New Initiatives Showing Encouraging Results

SHERMAN OAKS, CA / ACCESSWIRE / May 17, 2024 / Avenir Wellness Solutions, Inc. (OTCQB:AVRW) ("Avenir" or the "Company"), a proprietary broad platform technology and wellness company, today announced results for the fourth fiscal quarter ended December 30, 2023.

Key financial highlights for the fourth quarter included the following:

Net revenue in the fourth quarter of 2023 increased to $1.1 million from the same period in 2022 by $0.2 million, or 11.7%, and also increased sequentially from Q3 2023 by $43 thousand, or 4.4%. Overall growth was lower than expected due to the continued delay in receiving the expected remainder of the asset sale proceeds to be used for advertising and marketing to drive sales. The quarter did, however, benefit from a new relationship with leading online and beauty subscription box retailer, FabFitFun.

Gross margin increased 407 basis points year over year in the fourth quarter of 2023 due to improved working capital management offset in part by a higher proportion of sales coming from our wholesale channel of distribution with its lower margins than our higher-margin direct-to-consumer sales channel.

Gross margin for the third quarter of 2023 decreased sequentially from the second quarter of 2023 by 26 basis points due to a shift in sales channel mix with a higher proportion of wholesale sales to Amazon and FabFitFun which resulted in shipments of approximately $0.3 million.

Cost containment initiatives led to a favorable impact on SG&A expenses (excluding non-cash charges) for the fourth quarter with a decrease of $357 thousand in 2023 compared to 2022 driven by decreased spend on advertising and promotion of $325 thousand lower overhead by $32 thousand.

Net operating loss from continuing operations (excluding non-cash charges) improved by $0.9 million in 2023.

"Our products continue to maintain sales levels which is encouraging given that we have been unable to fully execute on our marketing initiatives pending receipt of the balance of the proceeds from the July 2022 asset sale. As mentioned in our third quarter earnings announcement, the proceeds from the July 2022 asset sale allow us to invest in the future of the Company, but the delay in receiving the balance of the proceeds continued to have an impact on our operating performance. We expect accelerating sales will reaffirm the improving overall trajectory of the business. Further, our margin expansion initiatives continue to deliver results with improvement from third quarter, and we continue our overall cost containment initiatives to further reduce SG&A expenses and to maximize operating leverage.

Fine tuning our Search Engine Optimization (SEO), bringing our media buying in house and achieving successful monthly campaigns like theSkimm continue to deliver for us as we execute on our strategy to build our brands," said Nancy Duitch, Avenir CEO.

Operational Highlights

Other operational highlights during the fourth quarter of 2023 included:

Our newly formulated Seratopical Revolution Cracked Heel Souffle was selected for inclusion in FatFitFun's Summer 2024 subscription box selling out an astonishing 80,000 units in under 43 minutes. Click link to view Instagram videos on our Cracked Heel Souffle.
Our DNA Complex hero product continues to perform as our subscription based grows.
Wholesale sales led by Amazon continue to grow with all the positive product reviews.
We began development of our new TikTok shop to capitalize on the evolving digital ecommerce landscape which launched in the second quarter of 2024.
For further details, please visit our website to review our most recent Form 10-K filed on May 17, 2024 at: http://www.avenirwellness.com/sec-filings/

About Avenir Wellness Solutions, Inc.

Avenir Wellness Solutions, Inc. (OTCQB:AVRW) is a broad platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems which are integrated into our wellness and beauty products and sold directly to the consumer. The technology, which is based on (15) fifteen current patents, offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The Company will continue down the path of creating new technologies that is part of its incubator strategy in order to monetize its intellectual property as well as expand our product lines utilizing the technology. As a vertically integrated platform company, Avenir looks to partner or license its IP technology with wellness companies worldwide. For more information visit: www.avenirwellness.com.

About The Sera Labs, Inc.

Sera Labs, a wholly owned subsidiary of Avenir, is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting-edge technology. Sera Labs creates high-quality products that use science-backed, proprietary formulations. More than 25 products are sold under the brand names Seratopical™, Seratopical Revolution™, SeraLabs™, and Nutri-Strips™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories of beauty, health and wellness, Sera Labs products are sold direct-to-consumer (DTC) via online website orders, including a subscribe and save option, and also sold online and in-store at major national drug, grocery chains, convenience stores, and mass retailers and on Amazon.com. For more information visit: www.seralabshealth.com and follow Sera Labs on Facebook, Instagram and TikTok at @seratopical as well as on X (Twitter) at @sera_labs.

Forward Looking Statement

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which statements are subject to considerable risks and uncertainties. Forward-looking statements include all statements other than statements of historical fact contained in this press release, including statements regarding the future growth and success of our organization. We have attempted to identify forward-looking statements by using words such as "anticipate," "believe," "could," "estimate," "expected," "intend," "may," "plan," "predict," "project," "should," "will," or "would," and similar expressions or the negative of these expressions.

Forward-looking statements represent our management's current expectations and predictions about trends affecting our business and industry and are based on information available as of the time such statements are made. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy or completeness. Forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements predicted, assumed or implied by the forward-looking statements. Some of the risks and uncertainties that may cause our actual results to materially differ from those expressed or implied by these forward-looking statements are described in the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as well as in our Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. Except as required by applicable law, we expressly disclaim any intent or obligation to update any forward-looking statements, or to update the reasons actual results could differ materially from those expressed or implied by these forward-looking statements, whether to conform such statements to actual results or changes in our expectations, or as a result of the availability of new information.

CONTACTS:

Investor Relations
Hanover International Inc.
T: [phone]
E: [e-mail]

[ProfitScout]

$AVRW: Avenir Wellness Solutions has never been in a better position to capitalize on the high intrinsic value of our unique and proprietary skin care formulations. With 15 patents under our control, the highly positive reviews Seratopical DNA Complex is receiving, and more new products in development, 2024 is set up to be a growth year for the Company. We look forward to keeping our shareholders informed of our progress, developments and milestones as we move forward.
Sincerely,
Nancy Duitch, CEO
News Link:
https://finance.yahoo.com/news/avenir-wellness-solutions-issues-2024-140000098.html

[ProfitScout]

$IVDN is on track for a record sales and revenue growth year in 2024, as detailed in official company news below. IVDN management is making steady progress to grow market share and also protect the very valuable patent rights of its unique Insultex product line which is the only evacuated cell insulation on the market with energy saving performance that no competitor can match.

IVDN is now starting to see accelerating sales success as word is spreading about Insultex House Wrap as described on the dedicated website at http://www.insultexhousewrap.com. Add to this advantage, the fact that the IVDN product meets or exceeds new building codes going into effect this year requiring continuous insulation while competitors are failing this critical criteria.

Innovative Designs Vendor Growth
April 10, 2024
https://finance.yahoo.com/news/innovative-designs-vendor-growth-174255528.html

World International Patent Organization (WIPO) Application Accepted on Superior Insulation Advancement to Maximize Global Marketing Opportunities for Innovative Designs, Inc.
Dec. 27, 2023
https://www.newmediawire.com/news/world-international-patent-organization-wipo-application-accepted-on-superior-insulation-advancement-to-maximize-global-marketing-opportunities-for-innovative-designs-inc-7071640

LIG Assets, Inc. Announces Agreement With Insultex House Wrap
October 30, 2023
https://www.globenewswire.com/en/news-release/2023/10/30/2769422/0/en/LIG-Assets-Inc-Announces-Agreement-With-Insultex-House-Wrap.html

Innovative Designs Inc. Receiving Orders From Numerous New Client Accounts for Top Performing Insultex House Wrap With Unmatched R-6 Insulation Value
October 26, 2023
https://www.globenewswire.com/news-release/2023/10/26/2767843/0/en/Innovative-Designs-Inc-Receiving-Orders-From-Numerous-New-Client-Accounts-for-Top-Performing-Insultex-House-Wrap-With-Unmatched-R-6-Insulation-Value.html

Innovative Designs Adds New Accounts
October 2, 2023
https://www.globenewswire.com/news-release/2023/10/02/2752606/0/en/Innovative-Designs-Adds-New-Accounts.html

[ProfitScout]

$GVH News: Globavend Holdings Limited Enters Into a US$20,000,000 Equity Line of Credit Facility to be Registered on Form F-1

PERTH, AUSTRALIA, March 18, 2024 (GLOBE NEWSWIRE) -- Globavend Holdings Limited (Nasdaq: GVH) (the “Company” or “Globavend”), an emerging e-commerce logistics provider, is pleased to announce that it has entered into a US$20,000,000 equity purchase agreement (the “Equity Purchase Agreement”) with Square Gate Capital Master Fund, LLC – Series 1 (“Square Gate”), as well as a registration rights agreement (“Registration Right Agreement”) related thereto. Pursuant to the terms of the Registration Rights Agreement, the Company will register the Company’s ordinary shares (the “Shares”) issuable to Square Gate under the Equity Purchase Agreement for public resale.

Globavend will have the right, but not the obligation, to sell to Square Gate up to US$20,000,000 worth of its Shares at Globavend’s sole discretion over the next 36 months, subject to certain conditions precedent and other limitations. Square Gate will have the obligation to purchase the Shares a price determined in accordance with certain formulas set forth in the Equity Purchase Agreement and subject to certain dollar caps.

Wai Yiu Yau, CEO of Globavend stated “This equity line facility provides Globavend with a viable long-term platform to grow its existing operations, expand its e-commerce logistics services into different verticals of the logistics supply chain, enhance its business presence in Australia, New Zealand and Hong Kong, and capitalize on other potential business opportunities. We are always mindful of the best interests of our shareholders and are committed to deliver solid financial performance for the company in 2024 and beyond.”

About Globavend Holdings Limited

Globavend Holdings Limited is an emerging e-commerce logistics provider offering end-to-end logistics solution in Hong Kong, Australia and New Zealand. The Company’s customers are primarily enterprise customers, being e-commerce merchants, or operators of e-commerce platforms, in providing business-to-consumer (B2C) transactions. As an e-commerce logistics provider, the Company provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution, from pre-carriage parcel drop off to parcel consolidation, air-freight forwarding, customs clearance, on-carriage parcel transportation and delivery.

Forward-Looking Statements

This press release contains certain forward-looking statements, including statements with regard to the Company’s proposed transaction and the future potential of the Company. Words such as “will,” future,” “expects,” “believes,” and “intends,” or similar expressions, are intended to identify forward-looking statements. Forward-looking statements are subject to inherent uncertainties in predicting future results and conditions and no assurance can be given that the proposed transaction discussed above will be completed on the terms described or achieve the objectives contemplated. Our ability to utilize the financing platform effectively and successfully are subject to numerous factors, many of which are beyond the control of the Company, including, without limitation, the failure of customary conditions precedent and the risk factors and other matters set forth in our annual report on Form 20-F. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.

For investor and media inquiries, please contact:
Company Info:
Globavend Holdings Limited
Wai Yiu Yau, Chairman and CEO
[e-mail] 61 08 6141 3263

https://www.globenewswire.com/newsroom/ti?nf=OTA2NDkzNiM2MTQwMDkzIzUwMDExOTk3MQ==
https://ml.globenewswire.com/media/MjM0ZWI4MTEtYjI1Zi00ZTg5LTgzZDktOGQ3YjYzMDNmNWFmLTUwMDExOTk3MQ==/tiny/Globavend-Holdings-Limited.png

Source: Globavend Holdings Limited

[ProfitScout]

$SMME: SmartMetric Says Credit Card Fraud Is Immense With Projected Global Losses Reaching an Astounding $43 Billion by 2026

January 22, 2024
NEW YORK--(BUSINESS WIRE)-- SmartMetric, Inc. (OTC: SMME) A biometric fingerprint credit card is better than regular credit cards in several ways. Here are some of the advantages of using a biometric card:

Enhanced security: A biometric card can verify your identity with your fingerprint, which is unique and difficult to forge. This can prevent unauthorized use of your card if it is lost or stolen. Unlike a PIN or a signature, your fingerprint cannot be guessed or copied by fraudsters.
Convenience: A biometric card can make payments faster and easier, as you do not need to remember or enter a PIN or sign a receipt. You just need to touch your finger on the card and insert or tap it on the reader. This can also reduce the risk of forgetting or losing your PIN.
Contactless payment: A biometric card can enable contactless payment, which is more hygienic and convenient than swiping or inserting your card. Contactless payment can also reduce the wear and tear of your card and the reader. Moreover, contactless payment can increase the transaction limit, as you do not need to enter a PIN for higher amounts.
The financial repercussions of credit card fraud are immense, with projected global losses reaching an astounding $43 billion by 2026. In the United States alone, credit card fraud losses are projected to exceed $12.5 billion within the next two years. These figures underscore the urgent need for implementing robust fraud prevention strategies and leveraging advanced technologies to protect consumers and businesses from financial harm. 1

Incorporating a biometric fingerprint identity scanner inside the credit card such as has been done by SmartMetric brings a powerful defense against credit card fraudsters using the power of biometrics.

The SmartMetric Gen 4 Biometric Fingerprint Card has been developed to meet the specific demand of the credit card industry and credit card users for enhanced credit card security. The card has an in-the-card nano fingerprint scanner that is used to recognize the card holder’s fingerprint and on a fingerprint match, instantly turning on the card.

“The mass market version of the SmartMetric Gen 4 biometric credit card is now under manufacture following the successful testing of the card's new and advanced internal operating system on the new card hardware platform,” said SmartMetric's President and CEO, Chaya Hendrick.

The SmartMetric biometric fingerprint recognition technology built inside of the credit and debit card uses embedded biometric technology to positively recognize the card holder, and then only after a positive fingerprint recognition, turn on the card's EMV contact and contactless payments chip.

According to an article published by Finder.com 2 the number of credit card accounts open in the United States is 564,500,000. This is an all-time high for the United States.

The average American owns three credit cards. 83% of Americans own at least one credit card. 14% of Americans own at least 10 credit cards.

To view the SmartMetric Biometric Card please follow this link - Video of the SmartMetric Biometric Card. To view the company website: www.smartmetric.com

1 Credit Card Fraud in 2023 - Credit Card Processing and Merchant Account (clearlypayments.com)
2 2023 Credit card debt and spending statistics in the US | finder.com

Safe Harbor Statement: Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Also such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, among others, if we are unable to access the capital necessary to fund current operations or implement our plans for growth; changes in the competitive environment in our industry and the markets where we operate; our ability to access the capital markets; and other risks discussed in the Company's filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K, which filings are available from the SEC. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Investors and security holders are urged to carefully review and consider each of SmartMetric Inc. public filings with the SEC, including but not limited to, if applicable, Annual Reports on Form 10-K, proxy statements, Current Reports on Form 8-K and Quarterly Reports on Form 10-Q.

https://cts.businesswire.com/ct/CT?id=bwnews&sty=20240122652997r1&sid=acqr8&distro=nx&lang=en
View source version on businesswire.com: https://www.businesswire.com/news/home/20240122652997/en/

SmartMetric, Inc.
Chaya Hendrick
Tel: [phone]
Mobile: [phone] (Pacific Time)
[e-mail]
http://www.smartmetric.com

Source: SmartMetric, Inc.

[ProfitScout]

$IVDN (16 million float): Superior Advancement for High Energy Efficiency Insulation Drawing Rising Interest and Commercial Demand; New International Patent Application Accepted to Maximize Marketing Potential
Feature Link:
https://markets.financialcontent.com/startribune/article/getnews-2023-12-28-superior-advancement-for-high-energy-efficiency-insulation-drawing-rising-interest-and-commercial-demand-new-international-patent-application-accepted-to-maximize-marketing-potential-ivdn

From the article:

Very Small Stock Structure of Only 37 Million OS / 16 Million Float

- Sole Maker of Patented Insultex® Insulation Delivering Energy Saving Performance Far Superior to All Competition.

- Unique Evacuated Cell House Wrap Material Provides an Unmatched R-6 Rating Plus a Water Vapor, Air, and Wind Barrier and Other Superior Benefits.

- World International Patent Organization Application Accepted to Maximize Global Marketing Opportunities.

- "Leader in Green Assets" LIG Assets, Inc., in Association with Robert Plarr, Signs Sales and Licensing Agreement with IVDN.

- Insultex House Wrap® Already Being Installed by LIG Assets in Conjunction with Their Plans to Acquire Firm Doing $100-200 Million in Annualized Sales.

- Over a Dozen New Sales Accounts were Added in the Fiscal Fourth Quarter with Orders Being Fulfilled for Superior Insultex® House Wrap.

- New Building Codes Require Higher Insulation Performance and IVDN Meets or Exceeds These New Standards Where Many Competitors Do Not.

- Increased Order Fulfilment Capabilities Recently Added with Plans for Further Enhancement to Handle Increasing Customer Demand.

- New Sales Accounts Include Large-Scale Commercial Modular Construction Firm Guerdon, LLC.

- Greater Energy Savings from Insultex® Insulation Delivers Substantial Economic Gains and Tax Credits for the User and Also Carbon Reduction for the Environment.

- Insider Buying from Board Member with Lockheed Martin & NASA Background.

[ProfitScout]

$RWGI News: Rodedawg Intl. Ind, Inc. (OTC:RWGI) Acquires Parabola Mgmt., LLC

Acquisition Completes and Establishes Key Revenue Drivers

COSTA MESA, CA / ACCESSWIRE / December 27, 2023 / Rodedawg International Industries, Inc. (OTC PINK:RWGI) proudly announces the company has completed all terms and conditions of the Parabola Mgmt., LLC acquisition.

Chris Swartz, CEO, states: "We are proud to announce to our shareholders the completion of the acquisition of Parabola Mgmt. LLC. The acquisition included ownership of the California licensed cannabis company in Costa Mesa with options to purchase additional licenses. Most importantly, the Costa Mesa facility is now open, operational, and is geographically located in Southern California which is the #1 market in the world for cannabis. The completion of all terms for this acquisition of Parabola Mgmt. LLC is "the" major step for Rodedawg shareholders. Rodedawg now has a central sales hub for upcoming sales and distribution efforts. This has been a step-by-step process and we have strategically executed this key milestone. In addition to this acquisition, our shareholders can expect in the coming weeks that we will complete the acquisition of additional licensed cannabis distribution hubs and distribution contracts that will have 2024 revenues meet our stated goals of 7 million annually."

Chris Swartz, CEO, adds, "We want to remind our shareholders of the importance of these key milestones as we anticipate that these milestones completed during this 4th Quarter 2023 to be the catalyst of our company's revenue growth:

We are finalizing the agreements for distribution, management, and manufacturing of new cannabis products that increase revenues by an estimated 7 million dollars annually.
Our www.BrotherBuds.com team has finalized the product catalog and we will notify our shareholders of the launch of the cannabis delivery service.
We expect to announce acceptance of an offer for our new Healthcare Division Director. Primary responsibilities include the continued launch of and our flagship product of www.Elixicure.com, our topical pain relief brand.
We are currently in negotiation for an additional licensed cannabis distribution hub to be owned 100% by Rodedawg Intl. Ind. Inc.
Mr. Swartz concludes: "This is an exciting time for our company, and our team thanks our loyal shareholders for their ongoing support. We also want our shareholders to know that no reverse split is planned for the company."

About Rodedawg International Industries, Inc.
Rodedawg International Industries, Inc. (OTC PINK:RWGI) is focused on providing management services, acquisitions and restructuring resources throughout the regulated California cannabis market. We are a trusted partner and asset to licensed cultivation, distributors, manufacturers, and retail dispensaries.

Please note the company's Twitter address is https://twitter.com/RWGImerger for regular updates.

About Budding Horizon, LLC
Budding Horizon, LLC is California Limited Liability Company with offices in Orange County, California. The company is focused to providing management services for the licensed cannabis industry and seeks to leverage its expertise in the real estate acquisitions to acquire and develop a portfolio of assets.

The company website is https://buddinghorizon.com/

About Brother Buds
Brother Buds is a cannabis delivery service based in Costa Mesa, California. During the month of July 2023, the Rodedawg will operate Brother Buds under a non-storefront cannabis delivery license. The cannabis delivery service will focus on Los Angeles County, Orange County, and northern San Diego County in the demographic area of 23.86 million in 2019. The company is focused to providing management services for the licensed cannabis industry and seeks to leverage its expertise in the real estate acquisitions to acquire and develop a portfolio of assets.

The company website is https://BrotherBuds.com

Make sure to follow us at: https://twitter.com/BrotherBudsOC

Contact Information:
Rodedawg International Industries, Inc.
1-800-793-0355
[e-mail]

Safe Harbor Statement: In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that would cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.

SOURCE: Rodedawg International Industries, Inc.
via PRISM Mediawire, LLC

[ProfitScout]

$CDSG RECEIVES MULTIPLE PROPOSALS FOR TITAN PROJECTS FROM LEADING GLOBAL COMPANIES

Las Vegas, NV. , Nov. 22, 2023 (GLOBE NEWSWIRE) -- Titan Lithium Inc., (OTC Markets: CDSG) (the “Company” or “CDSG”) a global lithium explorer, is pleased to announce that the Companies' Board of Directors are presently evaluating strategic proposals for future rapid development of the Titan projects in Tanzania.

Due to the uniquely strong Lithium results returned during our exploration, the Company has received several proposals in relation to development of the Titan projects. Both Titan 1 and Titan 2 have attracted a high degree of interest from a number of potential strategic partners, including global industry leaders in the mining industry.

In reviewing the received proposals, the management and Board of Directors of CDSG are deeply committed to both maximizing value for shareholders of the Company, as well as for the communities nearby the projects and for the viability of an actual robust production timeline for these world class projects.

We expect that any potential strategic partner of the Companies will be committed to contribute to the success of CDSG, support the interests of Tanzania and contribute in a major way to the supply chain to major Electric Vehicle markets.

Harp Sangha Chairman of the Board stated, "Titan Lithium is pleased by the strong interest in our projects from industry leaders which shows that even at such an early stage, the Titan projects are a standout and a potential new focal point for Lithium in the global supply chain.

Our strategic review process coincides with discussions with leaders in the Tanzania government as we plan our Phase 2 exploration program that will include a parallel effort to test the production readiness of the projects source materials. All alternatives will be thoroughly considered before any strategic partner is selected or any transaction is agreed upon. We would like to wish our shareholders a Happy Thanksgiving and we look forward to providing additional updates after the holiday.”

About the Company: China Dongsheng International Inc. (OTC Markets: CDSG), through its wholly owned subsidiary Titan Lithium, Inc., is a lithium explorer and developer with operations in Nevada, USA and The United Republic of Tanzania.

Contact:

Harp Sangha-Chairman

[e-mail]

[phone]

http://www.titanlithiuminc.com

Forward-Looking Statements:

This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Securities and Exchange Commission.

https://www.globenewswire.com/newsroom/ti?nf=ODk4MzMyMiM1OTM5NTkzIzUwMDEwMTQ0NA==
https://ml.globenewswire.com/media/YTAxYjU4MDAtOTdkZC00M2YyLThlMTYtNDQ2OTczOWI1OWY0LTUwMDEwMTQ0NA==/tiny/China-Dongsheng-International-.png

Source: China Dongsheng International Inc.

[andrethegiant1]

$SWISF 82 million customers waiting for sekur services next year https://finance.yahoo.com/news/sekur-private-data-ltd-track-133000532.html

[ProfitScout]

$SMME News: SmartMetric Says That Its Soon-to-be-Released Gen 4 Biometric Fingerprint Activated Credit Card Incorporates World's First Security Innovation Inside the Card
December 11, 2023

NEW YORK--(BUSINESS WIRE)-- SmartMetric, Inc. (OTC: SMME) reports that it has invented and implemented advanced new security features inside its world advanced biometric credit card.

“In order to ensure that only a fingerprint from a real person is being used, we have invented hardware-based live fingerprint detection inside the card, stopping the use of fake fingerprints from tricking the card's internal fingerprint recognition security,” said SmartMetric’s President and CEO, Chaya Hendrick.

“The live fingerprint detection security innovation built inside the SmartMetric biometric credit card makes it even more secure than biometrics fingerprint detection in today’s most recent mobile phones,” said SmartMetric.

Other security features such as separate storage of the user’s fingerprint in a highly encrypted secure memory in the card that is not exposed to outside hardware connectivity ensure the highest level of the card user's fingerprint security. No off-card storage or capture of the user's fingerprint ever takes place with the SmartMetric biometric card system, providing an ultimate level of protection for the card user.

The SmartMetric Gen 4 Biometric Fingerprint Card has been developed to meet the specific demand of the credit card industry and credit card users for enhanced credit card security. The card has an in-the-card nano fingerprint scanner that is used to recognize the card holder's fingerprint and, upon a fingerprint match, instantly turns on the card.

The SmartMetric biometric fingerprint-activated card is the only biometric card that allows for instant on-card fingerprint enrollment without the need for a special additional device to capture and enroll a card holder's fingerprint. This makes the SmartMetric biometric card especially suited for mass credit card issuers who rely on ease of card activation along with their use of mass new card issuance through the mail.

“Enrollment of a new card user's fingerprint on the SmartMetric biometric credit card is as simple as enrollment of a fingerprint for example as on a mobile phone while actually being even more secure than a mobile phone,” said Chaya Hendrick.

“The mass market version of the SmartMetric Gen 4 biometric credit card is now under manufacture following the successful testing of the card's internal software operating system with its new internal hardware on the new card platform,” said Chaya Hendrick.

Reports on credit card fraud are continuing to show an exponential growth in fraud rates in the United States. According to a report released this year by Security.org 1 151 million Americans have fallen victim to credit card fraud.

65 percent of credit and credit card holders have been fraud victims at some point in their lives, up from 58 percent last year. This equates to about 151 million Americans.
An increasing number of Americans have been victimized multiple times: in 2022, 44 percent of credit card users reported having two or more fraudulent charges, compared to 35 percent in 2021
Credit Card fraud is a growing issue for both card holders and card issuing banks. The biggest under-the-radar cost to the consumer is the add on fraud crimes that happen following a credit card fraud instance. A growing number of credit card fraud victims also become victims of other identity theft-based crimes which can be financially devastating to card fraud victims, according to SmartMetric.

“The need for a more secure credit and debit card is more needed today than ever before. That is why we have spent well over a decade in research and development to create a work-anywhere-at-anytime biometric-protected credit card,” said SmartMetric’s President & CEO, Chaya Hendrick.

The SmartMetric biometric credit card is the only advanced biometric payments card product with an internal rechargeable battery that allows the card to be used in all card usage cases such as restaurants and ATMs. Having its own power inside the card allows the SmartMetric biometric card to work prior to the card being inserted into a card reader.

The SmartMetric biometric fingerprint recognition technology built inside of the credit and debit card uses embedded biometric technology to positively recognize the card holder and then, only after a positive fingerprint recognition, turn on the card's EMV contact and contactless payments chip.

According to an article published by Finder.com 2 the number of credit card accounts open in the United States is 564,500,000. This is an all-time high for the United States.

The average American owns three credit cards. 83% of Americans own at least one credit card. 14% of Americans own at least 10 credit cards.

To view the SmartMetric Biometric Card please follow this link - Video of the SmartMetric Biometric Card. To view the company website: http://www.smartmetric.com

1 2023 Credit Card Fraud Report | Security.org
2 2023 Credit card debt and spending statistics in the US | finder.com

Safe Harbor Statement: Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Also such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, among others, if we are unable to access the capital necessary to fund current operations or implement our plans for growth; changes in the competitive environment in our industry and the markets where we operate; our ability to access the capital markets; and other risks discussed in the Company's filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K, which filings are available from the SEC. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Investors and security holders are urged to carefully review and consider each of SmartMetric Inc. public filings with the SEC, including but not limited to, if applicable, Annual Reports on Form 10-K, proxy statements, Current Reports on Form 8-K and Quarterly Reports on Form 10-Q.

https://cts.businesswire.com/ct/CT?id=bwnews&sty=20231211908778r1&sid=acqr8&distro=nx&lang=en
View source version on businesswire.com: https://www.businesswire.com/news/home/20231211908778/en/

SmartMetric, Inc.
Chaya Hendrick
Tel: [phone]
Mobile: [phone] (Pacific Time)
[e-mail]
http://www.smartmetric.com

Source: SmartMetric, Inc.

[ProfitScout]

$SMME News: SmartMetric Technology Bringing a Fully Functional Fingerprint Scanner Inside Your Credit Card, Taking Credit Card Security to the Next Level
November 15, 2023

NEW YORK--(BUSINESS WIRE)-- SmartMetric, Inc. (OTC: SMME) the miniature nano fingerprint scanner built by SmartMetric to fit inside a standard credit and debit card takes credit card security to the next level.

Before using your pin or any other clumsy old credit and debit card security, cards with the SmartMetric nano fingerprint scanner inside provide a powerful first step in securing the card prior to it being used. The card holders’ fingerprint is matched with their fingerprint that is scanned by the nano internal scanner each time the card holder goes to use their card.

A small square fingerprint sensor sits on the surface of the card that is connected to a circuit board inside the card. On this circuit board are extremely small and very low-profile electronic components that allow the users fingerprint to be scanned and matched in less then a second. On a fingerprint match the cards contact chip and contactless RFID is unlocked allowing the card to then operate at any standard card reader and ATM.

Enrolling a fingerprint on the card for the first time is as simple as enrolling your fingerprint on a mobile phone. Touch the sensor up to four (4) times and your fingerprint is then forever embedded inside the cards encrypted memory. The memory for storing the fingerprint is firewalled and uses extremely strong encryption.

“We had to build a super thin and small device that fits inside a standard credit card having amongst a number of components, a MCU, Power Management System, Internal Memory along with other components. Not to mention a super thin rechargeable hybrid nano battery,” said SmartMetric’s President and CEO, Chaya Hendrick.

Well over a decade of research and development has gone into creating the new GEN4 SmartMetric biometric card according to SmartMetric.

The new GEN4 card is now in mass production. A small sample run of the assembled card was completed to test the cards latest operating system developed by SmartMetric. The software testing and the cards functioning has been successfully completed.

“We are excited about the future prospects for our 'patent protected' product after spending so many years of research and development,” said Chaya Hendrick.

Patents for the technology have been issued recently in the United States while other patents covering other parts of the world have been filed.

“These recently issued patents disallow others from making biometric credit cards that have a fingerprint sensor on the card according to SmartMetric.”

“A massive market for an incredible next generation credit card,” said SmartMetric’s President and CEO, Chaya Hendrick.

Over 300 million credit cards have been issued in the United States. Consumer research reveals that up to 70% of existing credit card holders are willing to pay for a biometric secured credit card.

“The SmartMetric biometric credit card has taken years to develop and its Gen4 product designed for credit card issuing banks, is now in production said SmartMetric.”

The SmartMetric biometric fingerprint activated credit card brings the power of biometric security to the regular credit and debit card. Using the cardholder's own fingerprint only the cardholder is able to use the card. Touching the cards sensor on the cards surface awakens the card to scan the user’s fingerprint in less than a second. The fingerprint is matched with the users pre-stored fingerprint that has been registered inside the cards internal cryptographically secured memory.

“Research has shown that up to 70% of existing credit card users are attracted to using a biometric credit card. However, for this to be achieved the card itself must be as easy and simple to use as a current credit card and must most definitely be able to be biometric secured and safe in all card reading situations,” said Chaya Hendrick.

SmartMetric is now in mass market production of its GEN4 advanced biometric credit card. The company is preparing to release its advanced biometric credit card to the global credit card issuing community.

The SmartMetric GEN4 Biometric Fingerprint Card has been developed to meet the specific demand of the credit card industry and credit card users for enhanced credit card security. The card has an in-the-card nano fingerprint scanner that is used to recognize the card holders fingerprint and in turn activate the card.

The SmartMetric biometric credit card is the only advanced biometric payments card product with an internal rechargeable battery that allows the card to be used in all card usage cases such as restaurants and ATM’s. Having its own power inside the card allows the SmartMetric biometric card to work prior to the card being inserted into a card reader.

The SmartMetric biometric fingerprint recognition technology built inside of the credit and debit card uses embedded biometric technology to positively recognize the card holder and then only after a positive fingerprint recognition, turn on the cards EMV contact and contactless payments chip.

According to an article published by Finder.com1 the number of credit card accounts open in the United States is 564,500,000. This is an all-time high for the United States.

The average American owns three credit cards. 83% of Americans own at least one credit card. 14% of Americans own at least 10 credit cards.

SmartMetric plans to sell its advanced biometric credit card to card issuing Banks for $50.00 a card. In turn Banks will decide whether or not to provide the card for free to its card users or offer it as a premium card to its top tier card users for a fee.

To view the SmartMetric Biometric Card please follow this link - Video of the SmartMetric Biometric Card. To view the company website: http://www.smartmetric.com

1 2023 Credit card debt and spending statistics in the US | finder.com

Safe Harbor Statement: Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Also such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, among others, if we are unable to access the capital necessary to fund current operations or implement our plans for growth; changes in the competitive environment in our industry and the markets where we operate; our ability to access the capital markets; and other risks discussed in the Company's filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K, which filings are available from the SEC. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Investors and security holders are urged to carefully review and consider each of SmartMetric Inc. public filings with the SEC, including but not limited to, if applicable, Annual Reports on Form 10-K, proxy statements, Current Reports on Form 8-K and Quarterly Reports on Form 10-Q.

https://cts.businesswire.com/ct/CT?id=bwnews&sty=20231115029949r1&sid=acqr8&distro=nx&lang=en
View source version on businesswire.com: https://www.businesswire.com/news/home/20231115029949/en/

SmartMetric, Inc.
Chaya Hendrick
Tel: [phone]
Mobile: [phone] (Pacific Time)
[e-mail]
http://www.smartmetric.com

Source: SmartMetric, Inc.

[ProfitScout]

The latest update from SMME shows us how the company is still adding new advantages to its unequaled biometric credit card protection package. This company will deliver exactly what the market needs and wants today.

SmartMetric Biometric Credit and Debit Card With Inbuilt Fingerprint Recognition Secure Activation to Release Both Plastic and Metal Versions
October 16, 2023

NEW YORK, October 16, 2023--(BUSINESS WIRE)--SmartMetric, Inc. (OTC: SMME), following over a decade of research and development, is nearly ready to ship its advanced fingerprint activated credit and debit cards to the credit card industry.

"We are excited that after all these years of product development we are near shipping of not only our standard credit and debit card product as well as our premium version that is made of metal," said SmartMetric’s President and CEO, Chaya Hendrick.

The SmartMetric metal biometric card is the only one of its kind in the world that has embedded inside the metal the fingerprint scanner electronics at an extraordinary level of miniaturization and component slim height.

Creating a metal biometric credit card best fits the needs of the premium credit card market making it an attractive product for the high end credit card consumer who has become used to thinking of metal credit cards as a premium card product they are happy to have in their wallets.

"As with all new technology products SmartMetric believes that the top end of the market will be the first large scale adopters and therefor having our biometric card in metal makes sense for addressing this market," said Chaya Hendrick.

SmartMetric will continue to bring to market its standard plastic biometric credit card but in addition will offer its premium metal biometric credit card to card issuing financial institutions’.

The SmartMetric biometric credit card is the only advanced biometric payments card product with an internal rechargeable battery that allows the card to be used in all card usage cases such as restaurants and ATMs. Having its own power inside the card allows the SmartMetric biometric card to work prior to the card being inserted into a card reader.

The SmartMetric biometric fingerprint recognition technology built inside of the credit and debit card uses embedded biometric technology to positively recognize the card holder and then only after a positive fingerprint recognition, turn on the card’s EMV contact and contactless payments chip.

Market research has shown that 70% of current credit card users are willing to pay $70.00 for a biometric secured credit card. This is a low pricing limit with higher pricing for the card from banks to consumers very possible. The same research showed that nearly 70% of the existing 100s of millions of credit card users would prefer to use a biometric credit card for the added sense of security that a biometric card brings.

According to an article published by Finder.com1 the number of credit card accounts open in the United States is 564,500,000. This is an all-time high for the United States.

The average American owns three credit cards. 83% of Americans own at least one credit card. 14% of Americans own at least 10 credit cards.

To view the SmartMetric Biometric Card please follow this link - Video of the SmartMetric Biometric Card. To view the company website: http://www.smartmetric.com

1 2023 Credit card debt and spending statistics in the US | finder.com

Safe Harbor Statement: Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Also such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, among others, if we are unable to access the capital necessary to fund current operations or implement our plans for growth; changes in the competitive environment in our industry and the markets where we operate; our ability to access the capital markets; and other risks discussed in the Company's filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K, which filings are available from the SEC. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Investors and security holders are urged to carefully review and consider each of SmartMetric Inc. public filings with the SEC, including but not limited to, if applicable, Annual Reports on Form 10-K, proxy statements, Current Reports on Form 8-K and Quarterly Reports on Form 10-Q.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231016656873/en/

Contacts

SmartMetric, Inc.
Chaya Hendrick
Tel: [phone]
Mobile: [phone] (Pacific Time)
[e-mail]
http://www.smartmetric.com

[ProfitScout]

$SMME News: SmartMetric Fingerprint Activated Biometric Card Nears Shipping
October 5, 2023 (BusinessWire)

SmartMetric, Inc. (OTC: SMME) is soon to ship its completed advanced biometric fingerprint activated credit card. This is after extreme delays brought on by Covid related component delays.

"We are excited to be nearing the release finally of our advanced premium biometric fingerprint activated credit card after years of development and overcoming extreme component supply difficulties," said SmartMetric's President and CEO, Chaya Hendrick.

The market size of existing credit cards with chips on them is over 11 billion issued cards. As independent market research has evidenced that up to 70% of existing credit and debit card holders are keen to buy and pay for a new credit card or debit card with built in biometric fingerprint activation security, the actual market size for such cards runs into the multi-100's of millions of cards.

"SmartMetric has spent well over a decade in perfecting the miniaturization of its biometric card internal electronics. Creating a totally new product that pushes the limits of electronic component miniaturization and electronic mass assembly, has needed a great deal of perseverance and persistency," said Chaya Hendrick.

"We are excited about us being able to soon present our premium biometric card to card issuers around the world," said Chaya Hendrick.

ABOUT THE SMARTMETRIC BIOMETRIC CARD: Keeping your biometric identity safe is at the center of the design of the SmartMetric biometric card. At no time does a card holder's fingerprint leave the card. A person's fingerprint is stored inside the card and matching of the person's fingerprint is done on the card itself. This was a central design requirement of the SmartMetric biometric card solution that necessitated SmartMetric to create a self-powered inside the card, fully functional fingerprint scanner. Also, so that the card could be used at ATMs and POS (Point Of Sale) card readers, the SmartMetric development team created an on card miniature power management system that recharges the card as it is being used in card readers.

To view the SmartMetric Biometric Card please follow this link - Video of the SmartMetric Biometric Card

To view the company website: http://www.smartmetric.com

Spain moves to adopt biometric only credit cards: This Is The Change That Will Be Announced By Our Credit Card Banks (worldnationnews.com)

Safe Harbor Statement: Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Also such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, among others, if we are unable to access the capital necessary to fund current operations or implement our plans for growth; changes in the competitive environment in our industry and the markets where we operate; our ability to access the capital markets; and other risks discussed in the Company's filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K, which filings are available from the SEC. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.

Investors and security holders are urged to carefully review and consider each of SmartMetric Inc. public filings with the SEC, including but not limited to, if applicable, Annual Reports on Form 10-K, proxy statements, Current Reports on Form 8-K and Quarterly Reports on Form 10-Q.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231005938390/en/

SOURCE: SmartMetric, Inc.">

SmartMetric, Inc.
Chaya Hendrick
Head Office
702.990.3687 or 305.607.3910 (Pacific Daylight Time)
[e-mail]

[ProfitScout]

$SMME News: SmartMetric Announces It Has Received Export Approval for Its Biometric Card Following Testing and Authorization of Its Hybrid Solid State Rechargeable Battery Used in Its Advanced Biometric Fingerprint Activated Credit Card
September 21, 2023 (BusinessWire)

SmartMetric, Inc. (OTC: SMME) having spent months with regulators which involved extensive battery testing for airfreight clearance, the company is pleased to announce that it has received clearance to now ship its biometric card with its inbuilt rechargeable hybrid battery,

"We are very excited to have now overcome this last remaining hurdle to bring our advanced biometric fingerprint activated card to market," said SmartMetric's President and CEO, Chaya Hendrick.

The SmartMetric biometric credit card is the only advanced biometric payments card product with an internal rechargeable battery that allows the card to be used in all card usage cases such as restaurants and ATM's. Having its own power inside the card allows the SmartMetric biometric card to work prior to the card being inserted into a card reader.

The card user simply places their finger on the surface of the card, in less than a second the card reads the users fingerprint and matches with card holders' fingerprint permanently stored inside the card encrypted memory. "Only the legitimate card holder is able to turn on the card providing a level of credit card security way beyond existing credit cards," said Chaya Hendrick.

When SmartMetric first started on building its prototype biometric credit card over a decade ago, the overall thickness of the electronics was four times the thickness of a standard credit card. The company says that its overall thickness and profile of its electronics including the board and its internal battery is now less than one third the thickness of a standard credit card.

The SmartMetric rechargeable battery inside the biometric credit card allows the card to be used across all standard credit card readers at stores, gas pumps and even ATM's. Unlike non powered biometric cards that rely on drawing power from card readers in order to perform a biometric identification function thereby limiting the cards used and making it unworkable in most restaurants, gas pumps and ATM's.

Situations where the card is taken from the table in a restaurant or swallowed whole by the card reading device such as at a gas pump or ATM makes a card that does not have an internal rechargeable battery unworkable. That is why we have spent so much time and effort in including a rechargeable power source inside our biometric card that also includes a rapid rechargeability each time the card is inserted inside a credit card reader after it has already been turned on by the card holder's fingerprint according to SmartMetric.

The latest battery for the SmartMetric biometric card is going through final licensing and approvals for shipment via air from the SmartMetric assembly plant.

The SmartMetric biometric fingerprint recognition technology built inside of the credit and debit card uses embedded biometric technology to positively recognize the card holder and then only after a positive fingerprint recognition, turn on the cards EMV contact and contactless payments chip.

Market research has shown that 70% of current credit card users are willing to pay $70.00 for a biometric secured credit card. This is a low pricing limit with higher pricing for the card from banks to consumers very possible. The same research showed that nearly 70% of the existing 100's of millions of credit card users would prefer to use a biometric credit card for the added sense of security that a biometric card brings.

According to an article published by Finder.com (1)the number of credit card accounts open in the United States is 564,500,000. This is an all-time high for the United States.

The average American owns three credit cards. 83% of Americans own at least one credit card. 14% of Americans own at least 10 credit cards.

To view the SmartMetric Biometric Card please follow this link - Video of the SmartMetric Biometric Card. To view the company website: http://www.smartmetric.com

(1)2023 Credit card debt and spending statistics in the US | finder.com

Safe Harbor Statement: Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Also such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, among others, if we are unable to access the capital necessary to fund current operations or implement our plans for growth; changes in the competitive environment in our industry and the markets where we operate; our ability to access the capital markets; and other risks discussed in the Company's filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K, which filings are available from the SEC. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Investors and security holders are urged to carefully review and consider each of SmartMetric Inc. public filings with the SEC, including but not limited to, if applicable, Annual Reports on Form 10-K, proxy statements, Current Reports on Form 8-K and Quarterly Reports on Form 10-Q.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230921199989/en/

SOURCE: SmartMetric, Inc.">

SmartMetric, Inc.
Chaya Hendrick
Tel: [phone] Mobile: [phone] Pacific Time
[e-mail]
http://www.smartmetric.com

[ProfitScout]

$IVDN: Increasing Orders and Insider Share Purchase; Patented Evacuated Cell Insulation; Innovative Designs: Stock Symbol: IVDN
Click here:
https://www.einpresswire.com/article/637864225/increasing-orders-and-insider-share-purchase-patented-evacuated-cell-insulation-innovative-designs-stock-symbol-ivdn

From the article:

- $IVDN has a Very Small Stock Structure of Only 36 Million OS / 16 Million Float

- Sole Maker of Patented Insultex® Insulation Delivering Energy Saving Performance Far Superior to All Competition.

- Greater Energy Savings from Insultex® Insulation Delivers Essential Benefits of Economic Gains for the User and Carbon Reduction for the Environment.

- Significant New Orders for Insultex House Wrap® from Repeat Customers.

- Insider Buying from Board Member with Lockheed Martin & NASA Background.

- New US Patent Issued for Insultex® Manufacturing Process.

- International Distributor Agreement Signed with a Minimum Order Valued at $2 Million Per Year.

[Solarman]

$SYTA and $MMMW both had great press releases.

[Solarman]

$CYCA and $MMMW both making the world a better place.

[ProfitScout]

$CYCA News: Cytta Corp. Announces Global Medical Response's Decision to Upgrade to IGAN 2.0, Enhancing Incident Command Infrastructure

LAS VEGAS, NV / ACCESSWIRE / June 7, 2023 / Cytta Corp (OTCQB:CYCA), is pleased to announce that Global Medical Response (GMR), a long-time IGAN 1.0 industry customer, has elected to upgrade its incident command infrastructure to our new IGAN 2.0 AIMS (Actionable Intelligence Management System). This strategic decision by GMR will significantly enhance their ability to deliver critical care and emergency response services in future disaster situations worldwide.

GMR, as a prime contractor for FEMA, delivers comprehensive firefighting services, emergency medical response, emergency medical transportation and disaster management nationally through its 38,000 personnel. As the first responders to disasters of all kinds, GMR plays a pivotal role in mitigating risks, ensuring public safety, and preserving property.

"We are delighted to announce GMR's decision to upgrade to IGAN 2.0 after recent demonstrations conducted for the first time with a Drone America drone. The instant connectivity and integration of the IGAN 2.0 with the drone showed the versatility of our new product, " said Gary Campbell, CEO at Cytta Corp. "As GMR's trusted technology partner, we are proud to support GMR in their mission to protect lives and property. The full potential of what we built the IGAN for is realized in this application of the technology," further stated Mr. Campbell.

IGAN 2.0 is an advanced communications platform specifically designed for emergency response organizations. This state-of-the-art solution offers a comprehensive set of mission-critical tools including real-time video sharing, video/voice calls, chat interaction, streaming drone video, location maps, messages, and communications (video/voice/text). With end-to-end encryption and a user-friendly interface, IGAN 2.0 facilitates seamless and secure communication among drone pilots, ground teams, and the OEM Command Center, even in remote and challenging environments. With its robust network infrastructure, IGAN 2.0 ensures uninterrupted connectivity, even in challenging environments, empowering GMR to ensure continuity of operations, real-time situational awareness, and interagency operability.

Cytta Corp's expertise lies in developing robust and reliable communication platforms that address the unique challenges faced by emergency responders. Through extensive research and development, Cytta Corp has created state-of-the-art solutions that revolutionize communication infrastructure to support critical operations. Their commitment to excellence and continuous innovation positions them as a leader in the field, providing tailored solutions that empower GMR and all other first responders to deliver exceptional emergency response services.

About Cytta Corp.

Cytta Corp (OTCQB:CYCA): Cytta Corp develops and distributes proprietary software technology to shift how video/audio data is integrated, streamed, consumed, transferred, and stored. Cytta's proprietary IGAN 2.0 AIMS (Actionable Information Management System) integrates, in real-time, any available video and audio streams, enabling improved collaboration while providing relevant, actionable intelligence on an ongoing basis. Cytta's proprietary SUPR ISR (Intelligence, Surveillance, and Reconnaissance) codec delivers real-time compression of video streams through extremely low bandwidth with ultra-low latency. Cytta has created video/audio integration software with intelligence-gathering capability, advanced video compression, and portable/SaaS hardware/software systems that solve real-world problems in large markets.

For more information, please visit cytta.com and the Corporate Cytta Video Channel on YouTube to view Cytta's recent corporate discussion videos. Learn more at www.cytta.com.

Contact Us:

Cytta Corp

Phone: 855-511-IGAN (4265)

http://www.cytta.com

[e-mail]

Gary Campbell, CEO

Direct [phone] (or message)

[e-mail]

Natalia Sokolova, COO

Direct: [phone] (or message)

[e-mail]

John Bristol VP, Sales

Direct [phone] (please leave a message)

[e-mail]

SOURCE: Cytta Corp.

View source version on accesswire.com:

https://www.accesswire.com/759681/Cytta-Corp-Announces-Global-Medical-Responses-Decision-to-Upgrade-to-IGAN-20-Enhancing-Incident-Command-Infrastructure

[MrLangmeister]

$SYTA with another big news day today after great financials yesterday, view the link and video attached below for more

https://www.digitaljournal.com/pr/news/getnews/siyata-mobile-inc-nasdaq-syta-returns-to-growth-with-first-quarter-revenue-more-than-doubling-compared-to-the-first-quarter-last-year-on-strengthening-sales

[ProfitScout]

$CYCA News: Cytta Corp. and InvestorConnectAI Join Forces to Transform Shareholder & Investor Engagement and Unveil IGAN 2.0 Video Streaming Broadcast Technology

LAS VEGAS, NV and ORLANDO, FL / ACCESSWIRE / May 31, 2023 / Cytta Corp (OTCQB:CYCA), a leading provider of advanced communication and situational awareness technologies, is thrilled to announce its strategic partnership with InvestorConnectAI, a revolutionary A.I.-powered investor relations platform. This partnership aims to revolutionize shareholder engagement by combining Cytta's state-of-the-art IGAN 2.0 video streaming broadcast technology with InvestorConnectAI's advanced investor relations services.

IGAN 2.0, Cytta Corp.'s flagship low-latency video streaming and broadcasting technology, offers unrivaled quality and reliability for live video transmission. The newly introduced broadcast live-streaming feature provides all of the interactive video capabilities of products like Zoom and, in addition, military-grade video and audio encryption for enhanced privacy and security.

With its cutting-edge features and capabilities, IGAN 2.0 enables corporations, financial institutions, law enforcement agencies, government organizations, and businesses to securely live-stream high-definition video content in real-time, ensuring efficient and effective communication.

InvestorConnectAI's investor relations platform powered by IGAN 2.0 and AI is providing their clients with advanced tools to engage, communicate, and build strong relationships with their shareholder base and the retail investor community at large. By leveraging a full suite of generative A.I. and A.I.-powered tools, as well as data-driven insights, InvestorConnectAI enables clients to target and connect with the right investors, optimize messaging, and drive better results in its investor relations activities. This strategic partnership, and technology implementation will generate addition revenue for Cytta Corp.

"We are excited to partner with InvestorConnectAI to introduce the game-changing IGAN 2.0 video live-streaming technology," said Gary Campbell, CEO of Cytta Corp. "This partnership allows us to combine our cutting-edge video streaming capabilities with InvestorConnectAI's powerful investor relations platform."

The partnership between Cytta Corp. and InvestorConnectAI aligns with their shared vision of leveraging technology to transform the way live-streaming is conducted.

About Cytta Corp.

Cytta Corp (OTCQB:CYCA): Cytta Corp (OTCQB: CYCA) develops and distributes proprietary software technology to shift how video/audio data is integrated, streamed, consumed, transferred, and stored.

Cytta's proprietary IGAN 2.0 AIMS (Actionable Information Management System) integrates, in real-time, any available video and audio streams, enabling improved collaboration while providing relevant, actionable intelligence on an ongoing basis.

Cytta's proprietary SUPR ISR (Intelligence, Surveillance, and Reconnaissance) codec delivers real-time compression of video streams through extremely low bandwidth with ultra-low latency.

Cytta has created video/audio integration software with intelligence-gathering capability, advanced video compression, and portable/SaaS hardware/software systems that solve real-world problems in large markets.

For more information, please visit cytta.com and the Corporate Cytta Video Channel on YouTube to view Cytta's recent corporate discussion videos. Learn more at www.cytta.com.

About InvestorConnectAI:

InvestorConnectAI is a revolutionary A.I.-powered investor relations platform that helps companies optimize their investor outreach and engagement efforts. With advanced technology and data-driven insights, InvestorConnectAI enables companies to target the right investors, enhance engagement, and streamline their investor relations activities. To learn more about them, please visit their website at www.investorconnectai.com.

Contact Us:

Cytta Corp

Phone: 855-511-IGAN (4265)

http://www.cytta.com

[e-mail]

Gary Campbell, CEO

Direct [phone] (or message)

[e-mail]

Natalia Sokolova, COO

Direct: [phone] (or message)

[e-mail]

John Bristol VP, Sales

Direct [phone](please leave a message)

[e-mail]

SOURCE: Cytta Corp.


View source version on accesswire.com:

https://www.accesswire.com/758220/Cytta-Corp-and-InvestorConnectAI-Join-Forces-to-Transform-Shareholder-Investor-Engagement-and-Unveil-IGAN-20-Video-Streaming-Broadcast-Technology

[Let's Roll]

$HMBL The commercial division has the first government approved wallet in the U.S.

[MrFinnie]

Read more >> https://bullish.link/ACGX

Alliance Creative Group, Inc. ACGX announce the results of Operations for the Three Months and Quarter

Ending March 31, 2023. Revenues for the quarter ending March 31, 2023 ("Q1 2023") were $845,676

Gross Profits for the quarter ending March 31, 2023 ("Q1 2023") were $845,676

Net Income for the quarter ending March 31, 2023 ("Q1 2023") were $75,909

The total assets on the Balance Sheet for the Alliance Creative Group as of 3/31/23 were $4,327,315

The total outstanding common shares as of March 31, 2023 ("Q1 2023") were 3,454,211 with 2,198,971 of those

shares in the float.The Company ended the quarter with $38,567 Cash on hand.

Total Stockholder Equity as of 3/31/23 was $739,236

[MrFinnie]

Click Here to Read this full PR >> https://bullish.link/EPAZ_NEWS

We are advancing drone technology with artificial intelligence, and we need to protect our intellectual property, according to $EPAZ CEO Shaun Passley, PhD.

#BUYNOW
#HOTSTOCK

[Let's Roll]

$CBGL Quote https://www.otcmarkets.com/stock/CBGL/quote

[Let's Roll]

$CBGL is focused on multiple growing verticals within the global cannabis & CBD industry. This is accomplished through partnerships, acquisitions, and intellectual property.

[Let's Roll]

$CBGL Cannabis Global Completes Significant Debt Cancellations in Q1 - Over $800K in Debt Extinguishment - Actively Negotiating Additional Debt Settlements

https://feeds.issuerdirect.com/news-release.html?newsid=7256443189477382

[Let's Roll]

$EMED When it comes to electricity created in the human body, the energy source is chemical and has to do with the composition of the atoms and molecules present. All the elements we take into our bodies, such as oxygen, sodium, potassium, calcium, magnesium etc., have a specific electrical charge. How those molecules are bound together and how they react to other molecules near them is how chemicals create energy. Some of these electrical impulses found naturally in our bodies activate functions needed for healing.

[Let's Roll]

$EMED Electromedical’s commitment to create long-lasting drug-free solutions to pain management is honored by the development of The WellnessPro Plus®, a technologically advanced TENS (transcutaneous electrical nerve stimulation) therapy device focusing on pain relief.

[ProfitScout]

$NGTF News: Nightfood Announces Choice Hotels Qualified Vendor Status

TARRYTOWN, NY, March 16, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nightfood Holdings, Inc. (OTCQB: NGTF), the company pioneering the sleep-friendly nighttime snack category, is proud to announce its Qualified Vendor status with Choice Hotels International, Inc., one of the world's largest lodging franchisors.

Under this agreement, Nightfood’s sleep-friendly ice cream and cookies will be promoted to Choice franchisees for inclusion in hotel lobby marketplaces, and, potentially, as guest amenities.

The Choice Hotels portfolio expanded in 2022 to 22 brands and nearly 7,500 hotels, representing nearly 630,000 rooms, in 46 countries and territories. Choice’s brands include Comfort Inn®, Comfort Suites®, Quality®, Clarion®, Clarion Pointe™, Ascend Hotel Collection®, Sleep Inn®, Econo Lodge®, Rodeway Inn®, MainStay Suites®, Suburban Extended Stay Hotel®, WoodSpring Suites®, Everhome Suites®, and Cambria® Hotels.

“There’s a wellness trend sweeping over the hotel industry,” commented Nightfood CEO Sean Folkson. “Having sleep-friendly snacks available for guests’ nighttime snacking is a simple yet meaningful way for hotels to support wellness at an important touchpoint. Nightfood is honored to be aligned with Choice, their brands, and their franchise partners.”

About Nightfood

Nightfood is pioneering the category of sleep-friendly nighttime snacks.

Over 80% of Americans snack regularly at night, resulting in an estimated 700 million nighttime snack occasions weekly, and an annual spend on night snacks of over $50 billion. The most popular choices are ice cream, cookies, chips, and candy. Recent research confirms such snacks, in addition to being generally unhealthy, can impair sleep, partly due to excess fat and sugar consumed before bed.

Nightfood’s sleep-friendly snacks are formulated by sleep and nutrition experts to contain less of those sleep-disruptive ingredients, along with a focus on ingredients and nutrients that research suggests can support nighttime relaxation and better sleep quality.

The brand is currently focused on establishing widespread national distribution of Nightfood ice cream, cookies, and other snack formats in the hotel vertical.

Hotels are increasingly focused on supporting guest wellness. The Company believes one important way for hotels to do that is by offering sleep-friendly snacks in their grab-and-go lobby shops.

With an estimated 56,000 hotels across the United States, expanding distribution into a significant number of those hotels is expected to lead to profitability, consumer adoption of the nighttime snack category, and a strategically defensible position from which category leadership can be maintained.

Questions can be directed to [e-mail]

By signing up at ir.nightfood.com, investors can receive updates of filings and news releases in their inbox.

About Choice Hotels®

Choice Hotels International, Inc. is one of the largest lodging franchisors in the world. With nearly 7,500 hotels, representing almost 630,000 rooms, in 47 countries and territories as of December 31, 2022, the Choice® family of hotel brands provides business and leisure travelers with a range of high-quality lodging options from limited-service to full-service hotels in the upper upscale, upper midscale, midscale, extended-stay and economy segments. The award-winning Choice Privileges® loyalty program offers members a faster way to rewards, with personalized benefits starting on day one. For more information, visit www.choicehotels.com.

Forward Looking Statements:

This current press release contains "forward-looking statements.” Statements in this press release which are not purely historical (including, but not limited to statements that contain words such as “will,” “believes,” “plans,” “anticipates,” “expects,” “intends,” “would,” “could” and “estimates”) are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, sales projections, potential customers, any products sold or cash flow from operations.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, (a) the inherent uncertainties associated with distribution of our products, (b) the market acceptance of our products and products under development at all levels of distribution and sale, including retail purchasers, wholesalers and distribution partners, hotel chains and possibly airlines, (c) the success and commitment of our distribution partners to access distribution channels and successfully engage with sellers of our products, including, supermarkets, hotel chains and possibly airlines, and our success in obtaining purchase orders from hotel chains, supermarkets and others, (d) competition from existing and new companies and products and (e) difficulties associated with obtaining financing on acceptable terms . These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Media Contact:
Marlene Oliver
[e-mail]
888-888-6444, x8

Investor Contact:
Simon Dang
[e-mail]
888-888-6444, x3

[ProfitScout]

$NGTF News: Nightfood Teams Up With Sonesta International Hotels Corporation to Offer Sleep-Friendly Snacks Across Multiple Hotel Brands

Eighth Largest Hotel Company in the US Launching Nightfood in Sonesta Select, Sonesta ES Suites and Sonesta Simply Suites Managed Properties

TARRYTOWN, NY, March 13, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nightfood Holdings, Inc. (OTCQB: NGTF), the company pioneering the sleep-friendly nighttime snacking category, announced today that Sonesta International Hotels Corporation (Sonesta) is the first hotel company to introduce sleep-friendly Nightfood ice cream pints across multiple brands. Sonesta is launching Nightfood into approximately 160 managed Sonesta Select, Sonesta ES Suites, and Sonesta Simply Suites properties nationwide during Sleep Awareness Week beginning on March 12, 2023.

Sonesta is the eighth largest hotel company in the United States, with approximately 1,200 properties totaling 100,000 guest rooms across 17 brands in eight countries. This launch is part of Sonesta's ongoing corporate-level commitment to guest sleep and wellness.

"At Sonesta, we recognize sleep is the foundation of wellness and we're excited to make Nightfood sleep-friendly ice cream pints available in lobby markets at select properties to satisfy our guests' cravings for a sweet treat before bedtime that won't disrupt their sleep," said Elizabeth Harlow, Chief Marketing & Brand Officer, Sonesta. "We're delighted to provide our guests the option to choose a Nightfood sleep-friendly snack that contains less sugar than traditional ice cream while formulated to support better sleep across Sonesta Select, Sonesta ES Suites and Sonesta Simply Suites managed properties nationwide."

"High-sugar and high-fat snacks before bed, in addition to being generally unhealthy, can impair sleep quality. With Nightfood, Sonesta is offering better choices when it comes to the most popular nighttime snack options. I commend Sonesta for adding sleep-friendly snacks and enhancing guest satisfaction by safeguarding the quality of their sleep," said Dr. Michael Grandner, Director of the Sleep and Health Research Program and Assistant Professor of Psychiatry, Psychology, Medicine, and Nutritional Sciences at the University of Arizona, and Nightfood advisor.

"Wellness is a major focus of the hotel industry and today's modern traveler. Nightfood is a great way for hotels to support guest wellness because nighttime is when cravings peak for calorie-dense foods and when people are most likely to succumb to unhealthy choices," commented Sean Folkson, Nightfood's CEO. "It's exciting to see how enthusiastic the entire Sonesta team is to provide innovative options supporting their guests' sleep wellness."

The first phase of the roll-out across the three Sonesta managed brands features Nightfood ice cream pints in Cookies n' Dreams and Midnight Chocolate flavors available for purchase in hotel lobby markets.

Nightfood recently launched sleep-friendly cookies, and has ice cream sandwiches, chips, and other snacks in the development pipeline. Sonesta will explore adding other Nightfood snacks nationally throughout 2023 and beyond to its market offerings.

Nightfood ice cream is not a drug or a dietary supplement. It is not intended to diagnose, treat, cure, or prevent any disease or medical condition.

About Nightfood

Nightfood is pioneering the category of sleep-friendly nighttime snacking.

Over 80% of Americans snack regularly at night, resulting in an estimated 700 million nighttime snack occasions weekly, and an annual spend on night snacks of over $50 billion. The most popular choices are ice cream, cookies, chips, and candy. Recent research confirms such snacks, in addition to being generally unhealthy, can impair sleep, partly due to excess fat and sugar consumed before bed.

Nightfood's sleep-friendly snacks are formulated by sleep and nutrition experts to contain less of those sleep-disruptive ingredients, along with a focus on ingredients and nutrients that research suggests can support nighttime relaxation and better sleep quality.

The brand is currently focused on establishing widespread national distribution of Nightfood ice cream, cookies, and other snack formats in the hotel vertical.

Hotels are increasingly focused on supporting guest wellness. The Company believes one important way for hotels to do that is by offering sleep-friendly snacks in their grab-and-go lobby shops.

With an estimated 56,000 hotels across the United States, expanding distribution into a significant number of those hotels is expected to lead to profitability, consumer adoption of the nighttime snack category, and a strategically defensible position from which category leadership can be maintained.

Questions can be directed to [e-mail]

By signing up at ir.nightfood.com, investors can receive updates of filings and news releases in their inbox.

Forward-Looking Statements:

This current press release contains "forward-looking statements." Statements in this press release which are not purely historical (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects" and "estimates") are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, sales projections, potential customers, any products sold or cash flow from operations.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, (a) the inherent uncertainties associated with distribution of our products, (b) the market acceptance of our products at all levels of distribution and sale, including retail purchasers, wholesalers and hotel chains, (c) the success and commitment of our distribution partners to access distribution channels and successfully engage with sellers of our products, including, supermarkets and hotel chains, and our success in obtaining purchase orders from hotel chains, supermarkets and others, (d) competition from existing and new companies and products and (e) difficulties associated with obtaining financing on acceptable terms . These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Media Contact:

Marlene Oliver

[e-mail]

888-888-6444, x8

Investor Contact:

Simon Dang

[e-mail]

888-888-6444, x3

[ProfitScout]

$NGTF: Nightfood Schedules Investor Conference Call for Tuesday, March 14, 2023 at 4:30PM Eastern

TARRYTOWN, NY, Feb. 22, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nightfood Holdings, Inc. (OTCQB: NGTF), the company pioneering the sleep-friendly nighttime snack category, announced today that the Company will hold an investor conference call on Tuesday, March 14, 2023 at 4:30PM Eastern.

On this call, the Company plans to provide updates on hotel distribution, upcoming hotel and airline tests of Nightfood cookies as amenities, and answer investor questions.

Investors and other interested parties may submit questions regarding the Company prior to the call to Stuart Smith at [e-mail] by 12:00 PM Eastern on Monday, March 13, 2023. Which questions will be addressed will be based on the perceived relevance to the general shareholder base along with the questions’ appropriateness in light of public disclosure rules.

To access the call on Tuesday, March 14, 2023 at 4:30 PM:

Dial-In Number: 1-857-232-0157

Access Code: 422095

For those unable to participate in the conference call at that time, a replay will be available at https://www.smallcapvoice.com/tag/ngtf/ shortly after the call has concluded.

About Nightfood

Nightfood is pioneering the category of sleep-friendly nighttime snacking.

Over 80% of Americans snack regularly at night, resulting in an estimated 700 million nighttime snack occasions weekly, and an annual spend on night snacks of over $50 billion. The most popular choices are ice cream, cookies, chips, and candy. Recent research confirms such snacks, in addition to being generally unhealthy, can impair sleep, partly due to excess fat and sugar consumed before bed.

Nightfood’s sleep-friendly snacks are formulated by sleep and nutrition experts to contain less of those sleep-disruptive ingredients, along with a focus on ingredients and nutrients that research suggests can support nighttime relaxation and better sleep quality.

The brand is currently focused on establishing widespread national distribution of Nightfood ice cream, cookies, and other snack formats in the high-margin hotel vertical.

Nightfood ice cream pints can be found in hundreds of hotels across the United States, including select locations of chains such as Courtyard by Marriott, Holiday Inn Express,

Springhill Suites, Hyatt Place, Fairfield Inn & Suites and more.

Hotels are increasingly focused on supporting guest wellness, and one way to do that is by offering healthier and sleep-friendly snacks in their grab-and-go lobby shops.

With an estimated 56,000 hotels across the United States, expanding distribution into a significant number of those hotels is expected to lead to profitability, consumer adoption of the nighttime snack category, and a strategically defensible position from which category leadership can be maintained.

Questions can be directed to [e-mail]

By signing up at ir.nightfood.com, investors can receive updates of filings and news releases in their inbox.

Forward Looking Statements:

This current press release contains "forward-looking statements.” Statements in this press release which are not purely historical (including, but not limited to statements that contain words such as “will,” “believes,” “plans,” “anticipates,” “expects,” “intends,” “would,” “could” and “estimates”) are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, sales projections, potential customers, any products sold or cash flow from operations.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, (a) the inherent uncertainties associated with distribution of our products, (b) the market acceptance of our products and products under development at all levels of distribution and sale, including retail purchasers, wholesalers and distribution partners, hotel chains and possibly airlines, (c) the success and commitment of our distribution partners to access distribution channels and successfully engage with sellers of our products, including, supermarkets, hotel chains and possibly airlines, and our success in obtaining purchase orders from hotel chains, supermarkets and others, (d) competition from existing and new companies and products and (e) difficulties associated with obtaining financing on acceptable terms . These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Media Contact:
Simon Dang
[e-mail]
718-635-2949

Investor Contact:
Stuart Smith
SmallCapVoice
[e-mail]
888-888-6444, x3

[Let's Roll]

$PVSP Positioning for Expansion

“Spinning out Artizen will allow us to properly capitalize the business to take advantage of multiple expansion opportunities to build on our existing foundation,” said German Burtscher, Chairman and Chief Executive Officer of Pervasip and Artizen.

https://seekingalpha.com/pr/19084459-pervasip-announces-artizen-spin-off

[Let's Roll]

$PVSP Built a solid finance and accounting infrastructure.

[tsongbird]

$BIEL ELECTROMAGNETIC PAIN RELIEF/BLOCKING: FEASIBILITY ASSESSMENT

https://ntrs.nasa.gov/api/citations/20205008893/downloads/2020ICA_Mullenax_report_24Sep20.pdf

ELECTROMAGNETIC PAIN RELIEF/BLOCKING: FEASIBILITY ASSESSMENT
page 15
The treatment method ranked first in this review was pulsed
shortwave therapy (PSWT), a low-power RF (MHz range)
transmitter operated adjacent to biological tissue at maximum
output (saturation) to modulate peripheral nerve activity.
ActiPatch is a very small wearable PSWT device that is FDA
approved for “adjunctive treatment of musculoskeletal pain”
[Anwar-Deen 2020]. It is low cost, low power, and boasts 97%
efficacy in reducing pain (85% over a 6-month period) [Staelin
2019]. The device can be secured to the body by physio tape and
the area causing pain is bounded by the device’s ring. The device
can be turned on and off, and the non-rechargeable battery is capable of 720 hours of operation
(one month continuous use). ActiPatch is sold OTC in local pharmacies for ~$30 [ActiPatch
2020].

[ProfitScout]

$CYCA News: Cytta Corp. CEO Interviewed on CEO Roadshow and Initiates Monthly CEO Roadshow Live Webinar Series for Investors

LAS VEGAS, NV / ACCESSWIRE / January 17, 2023 / Cytta Corp (OTCQB: "CYCA," the "Company") today announced that it will host a Virtual Roadshow webinar on Tuesday, February 1, 2023 at 11:30 am Eastern time.

Gary Campbell, CEO of Cytta, will be presenting an overview of the business model and growth initiatives in 2023. The webinar will be accompanied by a presentation and followed by a question-and-answer session, which can be accessed via the webcast link. To register for the webinar, please use the following link:

https://us02web.zoom.us/webinar/register/WN_dIey3G5iQDmQt_-uz-pTug

CEORoadshow.com also interviewed Cytta Corp. CEO, Gary Campbell to discuss the company's latest business developments and plans for 2023. The video interview is available at the following link:

https://ceoroadshow.com/ceoroadshow-interviews-gary-campbell-ceo-of-cytta-corp-otcqb-cyca/

About Cytta Corp.

Cytta Corp(OTCQB:CYCA) has created video/audio integration software with AI capability, advanced video compression, and portable/SaaS hardware/software systems that solve real-world problems in large markets. Cytta's IGAN 2.0 collaborative dashboard integrates all video and audio streams, enabling collaborative interactivity while providing relevant, actionable information on an ongoing basis.

The IGAN 2.0 is a cloud based SAAS communication network providing a multifunctional tool for sharing realtime video, video/voice calls and chat interaction. The interactive desktop/mobile user interface provides quick visual reference and multiparty collaboration with streaming video, location maps, messages, and communications (video/voice/text). The IGAN collaborative video, voice, chat and media integration tool makes it easy to share and store critical real time data, such as video feeds, images, chat, files, messages, location maps and media. IGAN's complete encrypted cloud accessibility allows access as a web application for desktop and mobile devices, or with native iOS and Android mobile apps, all with end-to-end encryption for all users.

The IGAN 2.0 is a practical, valuable, and irreplaceable tool for police, firefighters, first responders, emergency medical workers, industry, environmental and emergencies, security, military, and their command centers in a crisis. It also allows connected venues such as schools, malls, event venues, and religious locations to be connected and monitor their situation, as well as immediately make their data directly available to law enforcement during emergencies.

Cytta's products enable and empower the world to collaborate and consume higher-quality video/audio/information anywhere and anytime. For more information, please visit cytta.com and the new Corporate Cytta Video Channel on YouTube to view Cytta's recent corporate discussion videos.

About Capital Markets Connect & CEO Roadshow

Founded in 2006, CEO Roadshow and Capital Markets Connect are dedicated to the delivery of top-tier strategic advisory services that encompass investor and stakeholder relations, capital markets navigation, corporate communications and social media management for emerging growth companies. The team at CEO Roadshow has extensive experience working with innovative and emerging companies from around the globe. As a distribution and engagement platform, CEO Roadshow reaches thousands of individuals, retail and institutional investors, and stakeholders in its proprietary and extensive distribution network. For more information, go to https://ceoroadshow.com/.

Cytta Corp

Phone: 855-511-IGAN (4265)

http://www.cytta.com

[e-mail]

Gary Campbell, CEO

Direct [phone]

[e-mail]

Natalia Sokolova, Investor Relations

Direct [phone]

[e-mail]

SOURCE: Cytta Corp.

View source version on accesswire.com:

https://www.accesswire.com/735463/Cytta-Corp-CEO-Interviewed-on-CEO-Roadshow-and-Initiates-Monthly-CEO-Roadshow-Live-Webinar-Series-for-Investors

[ProfitScout]

$CURR News: CURE Pharmaceutical Letter to Shareholders

Investment in New Marketing Strategies Showing Encouraging Early Results

Enhanced Instagram & Media campaigns featuring Nicole Kidman highlighting Seratopical Revolution

Incubator Strategy Initiated with New Market Disruptor Products arriving 1H2023

SHERMAN OAKS, CA / ACCESSWIRE / December 15, 2022 / CURE Pharmaceutical Holding Corp. (OTCQB:CURR) CEO Nancy Duitch is providing an update to its shareholders on positive recent developments in the evolution and progress of the Company.

Dear Shareholders:

We would like to thank all of you for your continued support during this exciting time in our company's history. We also want to share some of the progress we have made in the short period of time since the asset sale at the end of July 2022 which allowed us to invest in the Company's transformational products and innovative marketing campaigns. We have been very busy executing on our strategy which we believe will increase shareholder value.

CURE's new business model is now focused on ‘The Future of Innovative Wellness' utilizing our broad platform technologies. The new and exciting delivery system technologies we are creating in the surging wellness and beauty markets position us well for accelerating sales of our very high margin innovative products. Technology and innovation along with our team's execution will help to distinguish Cure in the marketplace.

The Company's short and long-term growth strategy is to increase revenue with high margin products. We will do this by using our incubator strategy to grow the patent and product portfolios. Additionally, we will monetize the patented technology through multiple revenue streams including strategic partnerships and transactions. These initiatives, along with the Company's relationships with Nicole Kidman and other major social media influencers, will also help propel its wellness and beauty brands to become household names and to become a house of respected and recognizable quality brands.

The Value Proposition of the Company is supported by these pillars:

Technology - Providing innovative wellness solutions to fill current market gaps by ordinary supplement delivery systems.
Strong Patent Portfolio - Portfolio of over 15 critical patents, issued and pending. Monetize owned IP through licensing/asset sale of the technology while developing new proprietary patents.
Established Network - A trusted and reliable brand that is recognized for quality and commitment to its customers.
Growth Plans - Multiple strategies that will be used to expand patents and product offerings, improve cash flow and ensure profitability to include, strategic non-dilutive transactions, geographic licensing, mergers or acquisitions and joint venture partnerships.
Management Expertise - The team has several decades of experience in the wellness and beauty sectors utilizing innovative products with cutting-edge intellectual property.
Supporting the strategic direction of the Company, the research firm of McKinsey & Company has estimated consumer spending on wellness products and services to be more than $450 billion in the United States, and growing at more than 5 percent annually, with global sales topping $1.5 trillion.They stated: "Consumers are eager to find solutions that work. The companies that thrive will be those that can identify and target unmet needs through offerings that are thoughtful, differentiated, tailored, and - increasingly - that target multiple dimensions of wellness."

Along with the wellness market place the Company is also heavily involved in the beauty industry which exceeds $530 billion in the U.S. alone. This is an arena in which the Company has excelled in the past and will continue to grow due to our branding and marketing expertise with a multi-channel Return on Investment advertising strategy. We are very proud of the unique and cutting-edge delivery system technologies which differentiate our products from those of other companies, and that is allowing us to grow with a limited amount of competition. We recently completed our new Seralabshealth.com website which is very user friendly and is showing huge improvement in conversions which leads to increased sales.

We also recently hired Rick Petry who is one of the most renowned writers and direct marketers. In addition, we brought in Tracy Jankowski as our Vice President of Digital Marketing who is an expert in women's products and who has turned around our digital marketing and branding strategies in just seven short weeks upgrading our internal team without adding additional G&A expense.

We have worked at warp speed on building out our technology and product development as well as our A-plus team the past four months. Thus, giving us a jump start for Q1 2023. Most importantly, our high gross margin products are priced so they are affordable for everyone in these tough economic times. There is an interesting WSJ article called the "Lipstick Index" which outlines what consumers look for during these times: affordable products that make consumers feel better about themselves which falls into our categories and price points.

Link to WSJ article: https://www.wsj.com/articles/the-lipstick-index-is-back-11669256641?st=phgh12u9x1q58wg&reflink=desktopwebshare_permalink

As we have previously reported, other important company developments already include strong sales results and revenue growth. Plus, we completed sale of a portion of our platform technology intellectual property portfolio and related assets in July 2022 for $20 million of non-dilutive capital in total consideration. A portion of the cash proceeds was used to pay down certain debt obligations and the balance is being used for working capital and to grow the Company's intellectual property portfolio and its wellness and beauty brands. The Company retained 15 of its patents and will continue to be an incubator for future technologies and patents, which it intends to monetize through the commercialization of the technologies through product development or through the licensing/sale of the technologies.

CURE'S wholly owned subsidiary, The Sera Labs, also announced that six SKUs of its Seratopical Revolution skincare line with P3P, our proprietary delivery system, are now being sold at over 1,372 Walmart Stores as well as on Amazon.com.

Sera Labs also has garnered placement for its revolutionary oral thin film strip, Nutri-Strips™ on shelves at CVS, Amazon.com and Target.com. Nutri-Strips are proprietary to Sera Labs and are the result of years of research.

We are also fortunate to have enhanced engagement of our Brand Ambassador, award winning actress Nicole Kidman who has steadfastly been so supportive in product development and continues to help us with posting, videos, and PR (including her current series of Instagram posts for the holidays highlighted in Daily Mail Article linked below) which together with our quality products builds consumer awareness and trust. We have recently enhanced the reach and visibility of Nicole as part of the launch of our new transformational Seratopical Revolution campaign and the unveiling of our cutting-edge new delivery system for our plant-based skincare line. Nicole Kidman and I will have more prominence in these multi-faceted marketing programs including recent articles like the ones Daily Mail, Forbes and Impact Wealth. To view the articles, click on the following links:

Daily Mail Dec 12, 2022, Nicole Kidman reveals the secret to her age-defying skin

Forbes Oct 31, 2022 - Nicole Kidman Talks Skincare-And The Beauty Essentials She Always Has In Her Bag

Impact Wealth Oct 31, 2022 - The Powerful Impact of Beauty Market Revealed by CEO Nancy Duitch

Recent key operational highlights included the following:

Revenue in the third quarter surged 32.1% year-over-year and 58.9% sequentially from Q2 2022 to $1.8 million with further increases expected in Q4.

Gross margins for the third quarter improved by 123 basis points to 80.0% in 2022 compared to the same period in 2021 with expectations of continuing high margin sales with our new marketing initiatives.

SG&A expenses (excluding non-cash charges) for the third quarter decreased by $0.1 million in 2022 compared to 2021.

Cost reductions and operating leverage helped narrow operating loss (excluding non-cash charges) by $0.6 million in 2022 versus 2021 despite enhanced marketing investment.

We are very pleased with the direction of our operating results and accelerating sales in the third quarter which reflect the improving trajectory of the business. The proceeds from the recent asset sale will enable us to invest in the future of the Company. Our margin expansion initiatives continue to deliver results, and we are continuing our efforts to reduce SG&A expenses. We are also very excited about the launches of the advertising and marketing campaigns for our Nutri-Strips and Seratopical Revolution lines. And get ready for the launch of our exciting market disruptors developed by our team of formulators led by Rob Davidson, our Chairman and Chief Technical Officer, in the first half of 2023 which look very promising for the Company.

Sincerely,

Nancy Duitch, CEO

CURE Pharmaceutical Holding Corp.

CURE Pharmaceutical Holding Corp.

CURE Pharmaceutical is a broad platform technology company that develops proprietary nutraceutical and topical delivery systems and currently holds fifteen patents. The technology offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The Company will continue down the path of creating new innovative technology that is part of its incubator strategy.

About The Sera Labs, Inc.

The Sera Labs, Inc. ("Sera Labs"), a wholly-owned subsidiary of CURE, is a trusted leader in the wellness and beauty sectors utilizing cutting edge technology and high-quality products that use science-backed, proprietary formulations. More than 25 products are sold under the brand names Seratopical™, Seratopical Revolution™, SeraLabs™, and Nutri-Strips™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale and is strategically positioned to grow its beauty and wellness products into household brands. Sera Labs products are sold Direct to Consumer with a subscribe and save option, as well as in major national drug, grocery and mass retailers. For more information visit: Seratopicalrevolution.com, Seratopical.com, Seralabshealth.com and follow Sera Labs on Instagram at @seratopical, as well as on Twitter and Facebook.

Forward Looking Statement

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which statements are subject to considerable risks and uncertainties. Forward-looking statements include all statements other than statements of historical fact contained in this press release, including statements regarding the future growth and success of our organization. We have attempted to identify forward-looking statements by using words such as "anticipate," "believe," "could," "estimate," "expected," "intend," "may," "plan," "predict," "project," "should," "will," or "would," and similar expressions or the negative of these expressions.

Forward-looking statements represent our management's current expectations and predictions about trends affecting our business and industry and are based on information available as of the time such statements are made. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy or completeness. Forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements predicted, assumed or implied by the forward-looking statements. Some of the risks and uncertainties that may cause our actual results to materially differ from those expressed or implied by these forward-looking statements are described in the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, as well as in our Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. Except as required by applicable law, we expressly disclaim any intent or obligation to update any forward-looking statements, or to update the reasons actual results could differ materially from those expressed or implied by these forward-looking statements, whether to conform such statements to actual results or changes in our expectations, or as a result of the availability of new information.

Contacts:

Investor Relations

Hanover International Inc.

[phone]

[e-mail]

SOURCE: CURE Pharmaceutical Holding Corp.


View source version on accesswire.com:

https://www.accesswire.com/731950/CURE-Pharmaceutical-Letter-to-Shareholders

[Let's Roll]

$PVSP Key Highlights

Instead of focusing on a rollout of licensed Dabs and Vape4Less brands, the Company pursued an outright acquisition of those brands plus others, achieving more beneficial long-term value but not yet realizing respective revenue gains as indicated earlier.

Q3 shows margin improvement over Q2 as higher margin brands and products are coming online, a trend that will continue into Q4 2022.

The Company continues to pursue additional operational, financial, and legal restructuring to further clean and strengthen its balance sheet.

While expensive, the Company will continue to seek capital from available equity or debt sources.

The cannabis market on the Westcoast continues to see a dramatic post-pandemic retraction, creating a challenging environment for all producers, processors, and retailers. With an almost 18% contraction in retail revenues, massive oversupply, sustained downward price pressure and increasing costs, the industry is still months away from a recovery, although the bottom for pricing seems to have been reached.

https://www.morningstar.com/news/globe-newswire/8666987/pervasip-announces-3rd-quarter-financials

[ProfitScout]

$NGTF News: Nightfood Continues to Capture Strong Share of Hotel Location Ice Cream Pint Sales

Tarrytown, NY, Nov. 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nightfood Holdings, Inc. (OTCQB: NGTF), the company pioneering the sleep-friendly nighttime snacking category, today announced that independent sales data for September and October across a subsection of qualifying hotel lobby marketplaces show that Nightfood ice cream pints are capturing a significant percentage of hotel ice cream pint sales from industry-leading Haagen Dazs.

The reporting subset represents all 30 hotels across the country which only sold 2 brands of pint ice cream (Nightfood and Haagen Dazs) during the two-month period and for which point-of-sale purchase data is available. Hotels which only sold Nightfood pints were excluded from the analysis, as were hotels that sold more than two brands of pints.

Nightfood, which began appearing nationally in hotel freezers less than six months ago, captured over 39% of total ice cream pint unit sales against the iconic Haagen Dazs which launched in 1960. In 33% of those hotels, Nightfood outsold Haagen Dazs, head-to-head.

"We've always believed that Nightfood would sell well in the high-margin hotel environment, and all the data to date supports that belief," commented Nightfood CEO Sean Folkson. "Hotels don't need to sacrifice revenue or profit when they add sleep-friendly snacks to their lobby shop assortments in support of guest wellness and sleep."

The Company, which recently added sleep-friendly cookies to their product line, believes any hotel selling snacks has an obligation to make sleep-friendly snacks available for their guests.

Folkson continued, "There are 56,000 hotels in the U.S., and we believe Nightfood should be in every one of them. We're proudly sharing this independent sales data with hotel decision-makers as we work to secure additional distribution commitments and timelines with some of the largest brands in the hotel industry."

About Nightfood

Nightfood is pioneering the category of sleep-friendly nighttime snacking.

Over 80% of Americans snack regularly at night, resulting in an estimated 700 million nighttime snack occasions weekly, and an annual spend on night snacks of over $50 billion. The most popular choices are ice cream, cookies, chips, and candy. Recent research confirms such snacks, in addition to being generally unhealthy, can impair sleep, partly due to excess fat and sugar consumed before bed.

Nightfood's sleep-friendly snacks are formulated by sleep and nutrition experts to contain less of those sleep-disruptive ingredients, along with a focus on ingredients and nutrients that research suggests can support nighttime relaxation and better sleep quality.

The brand is currently focused on establishing widespread national distribution of its sleep-friendly snacks in the high-margin hotel vertical. Nightfood began rolling into hotels across the United States in May 2022. Management believes hotels have an obligation to help guests achieve better sleep at every touchpoint, and one way to do that is through the snacks hotels curated for guests in hotel grab-and-go lobby shops.

With an estimated 56,000 hotels across the United States, national distribution is expected to lead to profitability, consumer adoption of the nighttime snack category, and a strategically defensible position from which category leadership can be maintained.

Questions can be directed to [e-mail]

By signing up at ir.nightfood.com, investors can receive updates of filings and news releases in their inbox.

Forward Looking Statements:

This current press release contains "forward-looking statements." Statements in this press release which are not purely historical (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects" and "estimates") are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, sales projections, potential customers, any products sold or cash flow from operations.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, (a) the inherent uncertainties associated with distribution of our products, (b) the market acceptance of our products at all levels of distribution and sale, including retail purchasers, wholesalers and hotel chains, (c) the success and commitment of our distribution partners to access distribution channels and successfully engage with sellers of our products, including, supermarkets and hotel chains, and our success in obtaining purchase orders from hotel chains, supermarkets and others, (d) competition from existing and new companies and products and (e) difficulties associated with obtaining financing on acceptable terms . These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Media Contact:

Simon Dang

[e-mail]

718-635-2949


Investor Contact:

Stuart Smith

SmallCapVoice

[e-mail]

888-888-6444, x3

[FinlayS00]

The SEC’s approval of iQSTEL’s S1 filing is a big win for the company. It opens up new opportunities for growth and gives investors confidence in iQSTEL’s future prospects. With up to $15 million in funding available over the next 12 months, iQSTEL is well-positioned to continue its M&A campaign and drive shareholder value.

https://pubcoinsight.com/technology-stocks-13/

[ProfitScout]

$IVDN: World’s Most Energy Efficient House Wrap Ready to Aid in the Rebuilding of Florida Homes After Hurricane Ian: Innovative Designs, Inc. (OTCQB: IVDN)
By: Get News
October 19, 2022
Click here:
https://markets.financialcontent.com/bostonherald/article/getnews-2022-10-19-worlds-most-energy-efficient-house-wrap-ready-to-aid-in-the-rebuilding-of-florida-homes-after-hurricane-ian-innovative-designs-inc-otcqb-ivdn/

From the article:
In the wake of Florida’s Hurricane Ian, IVDN is now working to supply its unmatched, R-6 certified Insultex House Wrap® for the massive rebuilding effort that will be taking place over the next year or more. Billions of dollars of homes will have to be rebuilt in Florida. IVDN management is making a commitment to aid in this process as much as possible by delivering its Insultex House Wrap® that far outperforms all other home insulation products.

[Let's Roll]

$IJJP eCETP client enrollment.

Certified eCETP Operators

TOTALS CATEGORY

1 Nonprofit -Perpetual License

1 Nonprofit -eCETP User

1 For-Profit -eCETP Partner

Mandatory Training Program

TOTALS CATEGORY

2 Nonprofit -eCETP Users

1 For-Profit -eCETP Partner

https://stockhouse.com/news/press-releases/2022/10/14/ijj-corporation-expansion-activities-for-board-members-as-appointed-officers-the

[ProfitScout]

$NGTF: New message from CEO Sean Folkson: "Congrats to Best Western® Hotels & Resorts for making Nightfood sleep-friendly ice cream available to guests at this location in Anaheim."
https://www.linkedin.com/feed/update/urn:li:activity:6985600190304976896/

"Right there, between the 1,110 calorie Ben and Jerry's Chocolate Chip Cookie Dough, and the 1,240 calorie New York Super Fudge Chunk, your guests can choose sleep-friendly Nightfood Midnight Chocolate...310 calories for the entire pint!

Many hotel guests want better choices when nighttime cravings hit....

By offering sleep-friendly Nightfood, with 75% fewer calories, 40% more protein, 3x the fiber, and 75% less sugar, plus added calcium, magnesium, zinc, and vitamin B6, you're doing the right thing for your guests."

#hotels #hospitality #customerexperience #dotherightthing

[tsongbird]

$BIEL The future is now with Bioelectronics

Drug free healing is the new wave of the future.

DRUG-FREE RecoveryRx- an affordable, simple to use, wearable device that treats pain. recoveryrx.co #painmanagement #chronicpainmanagement #chronicpainrelief #painrelief #neuromodulation #electroceuticals #fdacleared #clinicallyproven

https://www.bielcorp.com/bioelectronics-recoveryrx-pain-relief-device-receives-clearance-from-cofepris-launching-distribution-in-mexico/

https://www.bielcorp.com/bioelectronics-corporation-enters-into-a-distribution-agreement-for-recoveryrx-in-spain-with-prim-group

[Let's Roll]

$PVSP Pervasip Corp., a developer of companies and technologies in high value emerging markets, owns Artizen Corporation and its subsidiary, Zen Asset Management LLC, a diversified asset management company founded to acquire, develop, and support companies and technologies in the cannabis industry. ZAM’s existing clients operate four licensed cannabis cultivation and one processing facility in Washington. Most of the biomass produced by these independent cultivators has been sold historically under the Artizen™ brand, including all-time top selling products in flower in Washington state. Additional information on Artizen-branded products is available online at www.artizencannabis.com. Pervasip additionally owns 5% of KRTL Biotech, Inc., a developer of biotechnologies with a focus on pharmaceutical applications of cannabinol and psilocybin. Additional information on KRTL is available online at www.krtlbiotech.com. Additional information on Pervasip can be found at www.pervasip.net.

https://www.barrons.com/articles/pervasip-announces-1-6-million-in-august-revenues-and-3rd-quarter-guidance-01663075206?mod=md_stockoverview_news

[tsongbird]

$BIEL sells in all these countries!

Countries now using $BIEL products ActiPatch/Recovery Rx/KT Recovery Wave/ Healfast Pet Patch Loop

USA https://www.bielcorp.com/ https://www.recoveryrx.co/ https://www.donjoyperformance.com https://www.kttape.com
Greece https://gmtpshop.com/shop/physicotherapeftika/siskeves-ilektrotherapias-tens/recovery-rx/
Spain https://www.prim.es/ https://www.docmorris.pt/pt/actipatch-alivio-para-el-dolor-de-espalda-baja/p-129328
Corsica https://www.docmorris.pt/pt/actipatch-kit-dolori-schiena-pharmatech-srl/p-306738
https://www.docmorris.pt/pt/actipatch-kit-dolori-schiena-pharmatech-srl/p-306738
Mexico https://globaltech.com.mx/
Saudi Arabia https://www.stada.com/
Bahrain https://www.stada.com/
Lebanon https://www.clinovations.com/
Qatar http://www.mdmedical.co/index.html
Oman http://www.mdmedical.co/index.html
United Arab Emirates http://www.mdmedical.co/index.html
Kuwait http://www.mdmedical.co/index.html
Slovenia https://protibolecinska-zanka.com/?fbclid=IwAR2pWP6ikD-vxB6XB5mGfH47CwWEuABcPbBaT0xb5YN9xGxz504xVuOKlCk
Poland https://www.ubuy.com.pl/en/product/2DQGJO8-kt-tape-kt-recovery-wave-electromagnetic-pain-relief-device
Romania https://www.directpharma.ro/
Estonia https://msa.sm.ee/ctrl/en/MeditsiiniSeade/andmed/17178 https://monger.eu/kttape/en/toode/kt-recovery-wave/
Lithuania https://www.ubuy.lt/en/product/MPTPWE-actipatch-knee-pain-advanced-long-lasting-relief-packaging-may-varry
Japan https://www.u-buy.jp/en/product/2DQGJO8-kt-tape-kt-recovery-wave-electromagnetic-pain-relief-device
United Kingdom https://www.kttape.co.uk/products/kt-recovery-wave-%E2%84%A2
https://www.healthstuff.co.uk/en/us/ActiPatch-Knee-Pain-Reviews/r-3215.aspx
https://www.chemist-4-u.com/
France https://www.docmorris.pt/pt/avafarma-dolor-7-dias/p-137623
Ireland https://www.inishpharmacy.com/p/actipatch-electromagnetic-pulse-therapy-back-pain/actipatch-back
Germany https://www.amazon.de/-/en/ActiPatch-Knee-Joint-Pain-Kit/dp/B00RLLMVNK
Austria http://www.actipatch.at/
Australia https://actipatch.com.au/
Canada https://airwaysurgical.ca/
New Zealand https://thebalancedpet.co.za/shop/healfast-therapy-petpatch-loop/
Italy https://oneglobebio.com/
Finland https://kir-fix.fi/kauppa/actipatch-laakinnallinen-laite-kroonisen-kivun-hoitoon/
Sweden https://www.actipatch.se/
Korea https://www.huons.com/eng/home.php?go=main
South Africa https://www.adcock.co.za/
Bangladesh https://www.facebook.com/mhplbd/
Taiwan http://www.abmt.com.tw/
China https://cicdtech.en.made-in-china.com/product/TZiasMQvCpYj/China-Drug-Free-Pain-Relief-Electromagnetic-Pulse-Medical-Physical-Therapy-Equipment.html